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ABSTRACT OF THE DISSERTATION 
 
Computational Elucidation of Selectivities and 
Mechanisms Performed by 
Organometallic and Bioinorganic Catalysts 
 
by 
 
Jessica Marie Grandner 
Doctor of Philosophy in Chemistry 
University of California, Los Angeles, 2017 
Professor Kendall N. Houk, Chair 
 Computational methods were used to determine the mechanisms and selectivities of 
organometallic-catalyzed reactions. The first half of the dissertation focuses on the study of 
metathesis catalysts in collaboration with the Grubbs group at CalTech. Chapter 1 describes the 
studies of the decomposition modes of several ruthenium-based metathesis catalysts. These studies 
were performed to better understand the decomposition of such catalysts in order to prevent 
decomposition (Chapter 1.2) or utilize decomposed catalysts for alternative reactions (Chapter 
1.1). Chapter 2.1 describes the computational investigation of the origins of stereoretentive 
metathesis with ruthenium-based metathesis catalysts. These findings were then used to 
computationally design E-selective metathesis catalysts (Chapter 2.2). While the first half of the 
dissertation was centered around ruthenium catalysts, the second half of the dissertation pertains 
to iron-catalyzed reaction, in particular, iron-catalyzed reactions by P450 enzymes. The elements 
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of Chapter 3 concentrate on the stereo- and chemo-selectivity of P450-catalyzed C-H 
hydroxylations. By combining multiple computational methods, the inherent activity of the iron-
oxo catalyst and the influence of the active site on such reactions were illuminated. These 
discoveries allow for the engineering of new substrates and mutant enzymes for tailored C-H 
hydroxylation. While the mechanism of C-H hydroxylations catalyzed by P450 enzymes has been 
well studied, there are several P450-catalyzed transformations for which the mechanism is 
unknown. The components of Chapter 4 describe the use of computations to determine the 
mechanisms of complex, multi-step reactions catalyzed by P450s. The determination of these 
mechanisms elucidates how these enzymes react with various functional groups and substrate 
architectures and allows for a better understanding of how drug-like compounds may be broken 
down by human P450s.  
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Chapter 1.1 
In Situ Catalyst Modification in Atom Transfer Radical Reactions with Ruthenium 
Benzylidene Complexes 
Juneyoung Lee, Jessica M. Grandner, Keary M. Engle, K. N. Houk, Robert H. Grubbs 
Introduction  
Since the first report of ruthenium-based catalysts in atom transfer radical addition (ATRA, 
also called Kharasch addition)1 and atom transfer radical polymerization (ATRP),2 this area of 
research has attracted widespread interest.3−14 Well defined ruthenium benzylidene complexes, 
commonly used as olefin metathesis catalysts, have also been reported to catalyze ATRA and 
ATRP.9,15−19 The ability of ruthenium benzylidene complexes to promote two reactions with such 
markedly different mechanisms has been utilized in various tandem reactions in which olefin 
metathesis and ATR reactions take place in one pot.20−22 Generally speaking, tandem catalysts, 
which catalyze multiple distinct reactions in one pot, are attractive synthetic tools that can simplify 
reaction procedures and reduce operational costs. An improved understanding of their mechanism 
can enable further catalyst development toward new applications. Among the many tandem 
catalysts that have been reported,23 ruthenium benzylidene complexes have been a topic of interest 
to our research laboratory. For example, our group has reported ring opening metathesis 
polymerization (ROMP)-ATRP tandem catalysis for the preparation of block copolymers of 1,5-
cyclooctadiene and methyl methacrylate (MMA).20 Since the ROMP process was more rapid than 
ATRP, excess PCy3 was added to the reaction and low-strain cycloolefins were employed to 
suppress the rate of ROMP. Using low-strain cycloolefins and excess phosphine, the rate of ROMP 
was suppressed to roughly the same rate as ATRP, allowing for productive tandem catalysis. While 
the mechanism by which ruthenium benzylidenes initiate and catalyze olefin metathesis has been 
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studied in great detail, little is known regarding the mechanism of ATR reactions promoted by 
these complexes. Herein, we present our findings regarding the mechanism of these reactions. We 
have performed kinetic studies of ATRA using various ruthenium benzylidene complexes. Under 
common ATRA conditions, these complexes were found to rapidly consume the alkene starting 
material, but not all of them promoted formation of the desired ATRA product. Our experimental 
results are consistent with a decomposed ruthenium species, rather than the ruthenium 
benzylidene, as the active ATRA catalyst in this system. These ATRA-active ruthenium 
complexes were further found to be inactive in olefin metathesis. We have attempted to identify 
the new ATRA-active ruthenium species. To do this, we employed NMR spectroscopy and X-ray 
crystallography. Finally, when this collection of ruthenium benzylidene complexes were tested in 
ATRP, we found that only the complexes that formed highly reactive ATRA catalysts were able 
to perform controlled polymerization, rather than redox-initiated free radical polymerization. 
Experimental Section 
Materials and Analytical Techniques. All reactions were carried out in dry vials with PTFE-faced 
silicone septa under an argon (Ar) atmosphere or in a Vacuum Atmospheres Glovebox under a 
nitrogen atmosphere, as specified. All solvents and reagents were purchased from Sigma-Aldrich 
and used without further purification unless otherwise noted. Fresh ampules of CDCl3 (Sigma-
Aldrich) were used in decomposition experiments of the ruthenium benzylidene catalysts. 
Complexes 1, 2, 3, 6, and 7 were obtained from Materia, Inc. Complexes 4 and 5 were prepared 
from 2 and 3, respectively, following literature procedures.24,25 1H NMR spectra were recorded on 
one of the following instruments: Varian Mercury (300 MHz), Varian Inova (500 MHz), or Bruker 
Ascend with Prodigy broadband cryoprobe (400 MHz). Gel permeation chromatography (GPC) 
was conducted on two Agilent PLgel 10 μm MIXED-BLS 300 mm × 7.5 mm columns with Agilent 
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P260 series pump and autosampler with Wyatt Dawn Heleos-II multiangle static light scattering 
detector and Optilab T-rEX differential refractive index detector with THF as an eluent. 
General Procedure for ATRA Catalyzed by Ruthenium Benzylidene Complexes. To an 8 mL vial 
with silicone septum cap equipped with a magnetic stir bar, complex 1 (62 mg, 0.75 × 10−1 mmol), 
MMA (106.84 μL, 9.99 × 10−1 mmol), and CHCl3 (0.8 mL, 9.98 mmol) were added. Anisole (10 
μL, 9.20 × 10−2 mmol) was added as an internal standard. The solution was degassed with Ar (g) 
for 10 min, and the reaction was initialized by immersing the reaction vessel into an oil bath 
preheated to the specified temperature (65 or 40 °C). The reaction was kept under Ar (g), and 
aliquots were removed at predetermined time points and analyzed by 1H NMR to monitor reaction 
progress over time. After 2 h, the solution was precipitated into petroleum ether and filtered to 
remove precipitated catalyst. Solvent and unreacted MMA were removed using a rotary 
evaporator. The yield of the product was calculated based on integration of 1H NMR resonances 
at 6.01 ppm (−CCl2H from the product) and 1.84 ppm (−CH3 from the product and byproducts). 
All of the ATRA reactions in this paper were performed following this general procedure using 
the same molar ratio of [catalyst]: [MMA]: [CHCl3]. 
Decomposition Study of Ruthenium Benzylidene Complexes. Inside the glovebox, an NMR tube 
was charged with the ruthenium complex and CDCl3 in the same molar ratio as specified in the 
general ATRA procedure. The NMR tube was capped with a septum, removed from the glovebox, 
and heated to 65 °C. 1H NMR spectra were collected at predetermined time points, and the integral 
of the benzylidene resonance (16−20 ppm, 1H) was plotted as a function of time. 
General Procedure for ATRA Catalyzed by Activated Ruthenium Complexes. To an 8 mL vial with 
silicone septum cap equipped with a magnetic stir bar, complex 1 (62 mg, 0.75 × 10−1 mmol), 
anisole (10 μL, 9.20 × 10−2 mmol), and CHCl3 (0.8 mL, 9.98 mmol) were added. The solution was 
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degassed with Ar (g) for 10 min and then heated to 65 °C, until the benzylidene 1H NMR resonance 
had completely disappeared. The reaction vessel was allowed to cool to room temperature, and 
freshly degassed MMA (106.84 μL, 9.99 × 10−1mmol) was added to the solution. The reaction was 
initialized by immersing the reaction vessel into an oil bath preheated to the specified temperature 
(65 or 40 °C) and was held under an Ar (g) atmosphere. Aliquots were removed at predetermined 
time points and analyzed by 1H NMR to monitor reaction progress over time. All of the ATRA 
reactions in this report with preactivated ruthenium benzylidene complexes were performed 
following this general procedure using identical concentrations. 
General Procedure for ATRA Catalyzed by Ruthenium Benzylidene Complexes with 5 equiv of 
PCy3. To an 8 mL vial with silicone septum cap equipped with a magnetic stir bar, complex 1 (62 
mg, 7.53 × 10−2 mmol), MMA (106.84 μL, 9.99 × 10−1 mmol), anisole (10 μL, 9.20 × 10−2 mmol), 
and CHCl3 (0.8 mL, 9.98 mmol) were added. PCy3 (105.64 mg, 3.77 × 10
−1 mmol) was then added, 
and the solution was degassed with Ar (g) for 10 min. The reaction was initialized by immersing 
the reaction vessel into an oil bath preheated to 65 °C and was held under an Ar (g) atmosphere. 
Aliquots were removed at predetermined time points and analyzed by 1H NMR to monitor reaction 
progress over time. Experiments with 2 and 3 were performed following this general procedure 
using identical concentrations and reaction conditions. 
RCM Catalyzed by 3 and Benzylidene-Decomposed (ATRA-Activated) 3. The reaction was 
performed following a literature procedure.26 Complex 3 (7.47 mg, 8.01 × 10−3 mmol) was 
dissolved in degassed CDCl3 (0.75 mL). For reactions catalyzed by decomposed 3, the solution 
was then pretreated at 65 °C until the indicated level of benzylidene decay (as monitored by 1H 
NMR) was observed. The catalyst solution was cooled to room temperature, and diethyl 
diallylmalonate (19.3 μL, 7.98 × 10−2 mmol) was added. The reaction mixture was brought to a 
5 
 
temperature of 30 °C for 1 h, after which point an 1H NMR spectrum was collected to calculate 
olefin conversion. 
Crystallization of ATRA-Activated 1 with Bipy. Complex 1 (62 mg, 0.75 × 10−1 mmol) was 
dissolved into 0.8 mL of CHCl3 (0.8 mL. 9.98 mmol) and was activated by heating at 65 °C until 
complete decay of the benzylidene peak in the 1H NMR spectrum was observed. The solvent was 
removed under vacuum, and the resulting powder was redissolved in a minimal amount of DCM, 
prior to addition of bipy (58.83 mg, 0.38 mmol). Pentane was slowly added to make a layer above 
the DCM, and the solution was allowed to stand unperturbed at room temperature until crystals of 
the complex formed. 
ATRA Catalyzed by Ru(III)Cl3 and PCy3 Complex. MeOH (0.8 mL) was added to Ru(III)Cl3 (15.54 
mg, 0.75 × 10−1 mmol) and PCy3 (42.02 mg, 1.50 × 10
−1 mmol), and the reaction mixture was 
heated to reflux overnight. The solvent was removed under vacuum. Benzene was added, and the 
solution was filtered through glass pipet with kimwipe plug. The filterate was again concentrated 
under vacuum to give a dried powder. To this solid, were added MMA (106.84 μL, 9.99 × 10−1 
mmol) and 0.8 mL of CHCl3 (0.8 mL. 9.98 mmol), followed by anisole (10 μL, 9.20 × 10−2 mmol) 
as an internal standard. The solution was degassed with Ar (g) for 10 min, and the reaction was 
initialized by immersing the reaction vessel into an oil bath preheated to 65 °C. 
ATRP Catalyzed by Ruthenium Benzylidene Complexes. To an 8 mL vial with silicone septum cap 
equipped with a magnetic stir bar, ethyl α-bromoisobutyrate (10 μL, 6.81 × 10−5 mmol), MMA 
(1.46 mL, 1.36 × 10−2 mmol), and complex 1 (56.07 mg, 6.81 × 10−5 mmol) were added. Toluene 
(681 μL) and anisole (10 μL) were added as the solvent and internal standard, respectively. The 
solution was degassed with Ar (g) for 10 min, and the reaction was initialized by immersing the 
reaction vessel into an oil bath preheated to 85 °C. Aliquots were removed at predetermined time 
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points and analyzed by 1H NMR and GPC to monitor, MMA conversion Mn, and dispersity (Đ) 
over time. All of the ATRP reactions in this report were performed following this same general 
procedure under identical reaction conditions. 
Results and Discussion 
Chart 1.1.1. Ruthenium Benzylidene Complexes 
 
This investigation was commenced by examining reaction kinetics of ATRA with a series 
of ruthenium benzylidenes commonly employed in olefin metathesis (Chart 1.1.1). All of these 
complexes have been previously reported to catalyze olefin metathesis, and 1 has been shown to 
be effective in ATR reactions.9,19 For ATRA, methyl methacrylate (MMA) was employed as a 
model substrate due to its well-established reactivity in ATRA and ATRP. Chloroform (CHCl3) 
was chosen as the coupling partner and reaction solvent since ATRA using this halogen donor has 
been studied extensively (Scheme 1.1.1). Reactions with all of the complexes shown in Chart 1.1.1 
were monitored over 2 h by measuring the MMA conversion at predetermined time points by 1H 
NMR spectroscopy (Table 1.1.1). By monitoring MMA conversion over reaction time (Figure 
1.1.2a and Table 1.1.1), it was found that five out of seven ruthenium benzylidene catalysts in the 
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study led to consumption of MMA. Complexes 6 and 7 were found to be unreactive in ATRA. 
Complex 3 containing a SIPr ligand was the most active, followed in order by 1, 4, 2, and 5. The 
final yield of the desired product 8 was generally higher with faster ATRA catalysts. For example, 
with complexes 1 and 3, >99% of consumed MMA was converted to ATRA product, whereas 
greater discrepancies between MMA conversion and product yield were observed with 2, 4, and 
5. In these cases, MMA may have been consumed in undesired oligomerization/polymerization, a 
well-known side reaction of ATRA. Notably, no relationship between metathesis activity (or 
metathesis initiation rate) and ATR rate was observed within this series. Density functional theory 
(DFT) calculations were performed assuming a general mechanistic paradigm involving inner-
sphere electron transfer from an intact ruthenium benzylidene moiety to homolyze the 
carbon−halogen bond (Figure 1.1.1). However, predicted relative catalyst activities from 
computed ΔGrxn for this reaction with complexes 1−7 were not in agreement with the empirically 
observed reactivity trend. Additionally, the ΔGrxn values for the halogen abstraction step with most 
complexes were too endergonic for effective catalysis. This inconsistency prompted us to consider 
the stability of complexes 1−7 under the reaction conditions. 
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Figure 1.1.1. (a)  Computed ΔGrxn (kcal/mol) for chlorine atom transfer from CHCl3 to 
complexes 1–7. (Note: loss of the first pyridine, anti to the benzylidene, from 4 and 5 is exergonic 
by 4.7 and 5.1 kcal/mol respectively) (b) Computationally predicted order of ATRA activity. 
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Scheme 1.1.1. ATRA of MMA Catalyzed by Ruthenium Benzylidenes of Activated 
Ruthenium Complexes 
 
Solutions of each complex in CDCl3 without MMA were prepared at the same 
concentration used in the ATRA experiments. The diagnostic benzylidene proton peak was 
monitored by 1H NMR (16−20 ppm) over time at the reaction temperature (65 °C). Most of the 
catalysts were unstable in CDCl3, as evidenced by the disappearance of the benzylidene peak and 
appearance of new proton resonances far upfield of the benzylidene region. Complexes 6 and 7 
were stable for >4 h under these conditions (Figure 1.1.2b, Figures A.S2−A.S12). This 
decomposition process was found to be highly temperature and solvent-dependent. For example, 
with catalyst 4, no appreciable benzylidene decay was observed at a slightly reduced temperature 
of 55 °C for over 4 h. Complex 3 showed rapid benzylidene decay in CDCl3 but did not show any 
benzylidene decay in C6D6 until subsequent addition of an alkyl halide (Figure 1.1.2c). This 
indicates that the alkyl halide triggers benzylidene decomposition. Furthermore, complex 3 
exhibited a nearly identical benzylidene decay profile in CDCl3 containing added K2CO3. These 
results are consistent with the alkyl halide, rather than heat or trace HCl, as the component that 
drives benzylidene decomposition. Strikingly, the order of benzylidene decay rate in these 
stoichiometric experiments was the same order as MMA conversion in catalytic ATRA (Figures 
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1.1.2a and b). The correlation between benzylidene decay rate and ATRA rate prompted us to 
examine the extent to which the newly formed ruthenium species are active participants in ATRA 
reactions. 
Table 1.1.1. MMA Conversion and Product Yield of ATRA (2 h) with Different Ruthenium 
Benzylidene Complexes 
entry catalyst T (°C) MMA conv (%)a yield for 8 (%)b 
1 1 65 89 89 
2 2 65 45 7 
3 3 65 95 94 
4 4 65 79 61 
5 5 65 17 ∼0 
6 6 65 ∼0 ∼0 
7 7 65 ∼0 ∼0 
8 activated 1 65 97 86 
9 activated 3 65 99 93 
10 activated 4 65 86 68 
11 1 40 20 ∼1 
12 activated 1 40 41 28 
13 3 40 32 ∼2 
14 activated 3 40 85 70 
15 1 + 5 equiv PCy3 65 67 16 
16 2 + 5 equiv PCy3 65 40 ∼0 
17 3 + 5 equiv PCy3 65 69 ∼2 
aMMA conversion was calculated from 1H NMR integration using anisole as an internal 
standard. 
bProduct yield was calculated from 1H NMR integration, after first removing the ruthenium 
catalyst by precipitation into petroleum ether. 
To this end, the reactivity of the benzylidene-decomposed ruthenium species, formed from 
pretreatment of 1, 3, and 4 in CHCl3, was investigated. First, solutions of these catalysts in CHCl3 
were heated at 65 °C under Ar (g) in the absence of MMA until no benzylidene peak was observed 
in the 1H NMR spectrum. MMA was added, and reaction progress was monitored (Scheme 1.1.1). 
As shown in Table 1.1.1 and Figure 1.1.3a, the activated ruthenium complexes demonstrated faster 
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rates, providing equally high yield of the ATRA product. Given the pronounced temperature 
dependence of the stoichiometric benzylidene decay reactions, we next sought to determine the 
temperature dependence of ATRA reactivity. When ATRA reactions were run with 1 and 3 at 40 
°C, where no benzylidene decay was observed, MMA consumption proceeded slowly and only 
trace product formation was observed. In contrast, preactivated, benzylidene-decayed 1 and 3 
exhibited faster rate and provided greater product yields, even at 40 °C (Table 1.1.1). 
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Figure 1.1.2. Rate profiles of (a) ATRA promoted by ruthenium benzylidene complexes. Reaction 
conditions as in Scheme 1.1.1. (b) Benzylidene 1H NMR resonance decay of complexes 1−7 over 
time. Reaction conditions as in Scheme 1.1.1 in the absence of MMA. (c) Benzylidene 1H NMR 
resonance decay of complex 3 in CDCl3, neutralized CDCl3, and C6D6 with addition of ethyl α-
bromoisobutyrate after 1 h. In the neutralized experiment, excess K2CO3 solid was added to a 
freshly degassed CDCl3 solution, and the resulting heterogeneous mixture was shaken vigorously 
prior to heating. 
The data shown above indicate a reaction pathway for ATRA in which the ruthenium 
benzylidene is converted into one or more new ATRA-active ruthenium species under ATRA 
conditions. When activated, the new species exhibit superior reactivity in ATRA compared to the 
parent complexes, even at lower temperature. As is typical in ATR reactions, trials performed 
under our standard conditions were inhibited by O2. Consistent with this observation, the newly 
formed ruthenium species were found to be air-sensitive and were unreactive in ATRA after 
exposure to air. 
The effect of excess phosphine ligand in catalytic ATRA was also studied. The addition of 
tricyclohexylphosphine (PCy3, 5 equiv relative to catalyst) to solutions of the complexes altered 
the benzylidene decomposition trends (Figure A.S13). With complexes 1 and 2, the presence of 
additional PCy3 increased the rate of benzylidene decay. However, complex 3 showed slower 
decay than 1 and 2 under the same conditions. The origins of these effects are still under 
investigation. The rates of catalytic ATRA reactions with additional PCy3 using 1 and 2 were 
slightly inhibited by excess PCy3. The reaction with 3 became substantially slower, and the overall 
product yield was significantly reduced in all cases (Table 1.1.1 and Figure 1.1.3b). 
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Figure 1.1.3. (a) Kinetic study of ATRA of MMA catalyzed by 1, 3, and their activated analogues. 
(b) Effect of adding PCy3 (5 equiv) to ATRA catalyzed by 1, 2, and 3. Reaction condition same as 
in Scheme 1.1.1. 
The identity of the in situ generated ruthenium species was explored further. Complex 3 
was decomposed in CDCl3 to 40% completion and 100% completion (as measured by benzylidene 
1H NMR signal). It was found that an ATRA-activated sample of 3 with completely decayed 
benzylidene was inactive in ring-closing metathesis (RCM) of diethyl diallylmalonate (9), a highly 
reactive RCM substrate with complexes 1−7 (Scheme 1.1.2). In contrast, samples of untreated 3 
and 40%-benzylidenedecayed 3 catalyzed RCM with 9, providing 100% conversion to 10 after 1 
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h. These results, in conjunction with the 1H NMR data, prove that the ATRA-active ruthenium 
species does not contain a benzylidene/alkylidene moiety. 
Scheme 1.1.2. RCM Catalyzed by 3 and Benzylidene-Decomposed ATRA-Activated 3 
 
To gain more information regarding the structure of the ATRA-active species, we next 
turned to NMR spectroscopy and X-ray crystallography. As discussed above, upon decomposition 
of complexes 1 and 3 in CDCl3 at 65 °C, the 
1H and 13C NMR spectra revealed that the benzylidene 
moiety had fully dissociated. In the 31P NMR spectra of ATRA-activated 1 and 3, a substantial 
downfield shift of the major phosphine resonance was observed. In both cases, a major phosphine 
resonance at 108.10 ppm appeared upon decomposition (Figures A.S4 and A.S8). This peak is in 
an unusual region of the 31P spectrum, and we suspect that it could represent the corresponding 
dichlorophosphonium salt.27 The 31P NMR results along with the data from excess PCy3 
experiments shown above (Table 1.1.1 and Figure 1.1.3b) with 1 and 3, are consistent with a 
mechanism in which PCy3 is partially or fully dissociated from the ruthenium center in the active 
form of the catalysts. 
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Figure 1.1.4. X-ray crystal structure of Ru(II)Cl(PCy3)(bipy)2Cl
– formed from addition of bipy to 
ATRA-activated 1. Hydrogen atoms and solvent molecules were omitted for clarity. Pink, Ru; 
gray, C; yellow, P; blue, N; green, Cl (CCDC 1473173). 
In addition to NMR spectroscopy, we have attempted to obtain single crystals of ATRA-
activated ruthenium complexes 1 and 3 that would be suitable for X-ray diffraction. Despite 
numerous attempts, we were unable to grow suitable crystals directly from the decomposed 
solutions. However, after extensive experimentation we found that the addition of 2,2’- bipyridine 
(bipy, 5 equiv) to a solution of ATRA-activated 1 led to formation of a new species, 
Ru(II)Cl(PCy3)(bipy)2Cl
−, which we were able to crystallize and characterize by X-ray diffraction 
(Figure 1.1.4). Interestingly preliminary X-ray crystal structure data of the analogous experiment 
with activated 3 allowed tentative identification of another new complex, Ru(III)Cl3(PCy3)(bipy) 
(data not shown). In both cases, addition of bipy resulted in an upfield shift of the phosphine peak 
from 108.10 ppm (activated 1 and activated 3) to 49.80 ppm (Figures A.S4 and A.S8). Moreover, 
during an attempt to obtain an X-ray crystal structure of activated 3, we instead isolated and 
characterized the SIPr·HCl salt. In a separate experiment, when 3 was exposed to ethyl α-
bromoisobutyrate in C6D6 (Figure 1.1.2c), we were able to obtain colorless crystal from this 
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reaction mixture, which turned out to be the SIPr·HBr salt. Both of these results suggest that the 
NHC ligands are labile under these reaction conditions. 
Combining the insights from all of these experiments, we now suspect that the original 
ruthenium benzylidene complexes decompose under common ATRA reaction condition (65 °C in 
CHCl3) through complete dissociation of all L-type ligands (benzylidene, PCy3, and NHC) from 
the ruthenium metal center. We propose that a simple ruthenium chloride complex, such as 
Ru(III)Cl3 or Ru(II)Cl2 or a RuxCly cluster, possibly containing one or more bound phosphine 
ligands, is the actual ATRA-active species. To explore this possibility further, we attempted to 
perform ATRA with Ru(III)Cl3, which we found to be completely insoluble in CHCl3 even upon 
addition of MMA. To solubilize this complex, Ru(III)Cl3 was refluxed with PCy3 in MeOH 
overnight, concentrated in vacuo, suspended in benzene, filtered, washed with benzene and dried. 
The resulting ruthenium complex, presumably RuCl3(PCy3)n, was soluble in CHCl3 and 
successfully converted MMA to the ATRA product with 96% MMA conversion and 88% product 
yield (Figure A.S14). Also, the reaction kinetics with RuCl3(PCy3)n were faster than with 3 and 
were in perfect agreement with ATRA-activated 3. The newly prepared RuCl3(PCy3)n complex, 
however, did not show the same peaks in the 31P spectrum as activated 1 or activated 3 (108.10 
ppm). This experiment confirms that the phosphine peak from 108.10 ppm in ATRA-activated 3 
is a byproduct from the catalyst activation process and does not correspond to a ruthenium species 
that is involved in ATRA reactions. 
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Scheme 1.1.3. ATRP of MMA Catalyzed by Ruthenium Benzylidenes 
 
Lastly, we performed a series of experiments to test whether insights gained from this 
investigation were relevant to ATRP. ATRP and ATRA have similar mechanisms involving active 
radicals generated by a reversible redox process of halogenated substrates and transition metal 
complexes.28 In ATRP, a large excess of olefin leads to polymerization rather than a single radical 
addition. Ruthenium benzylidene complexes 1−5 converted MMA to polymer (Scheme 1.1.3, 
Figure 1.1.5). The order of reaction rates was similar to the previous catalytic ATRA, except that 
4 was the slowest in ATRP. However, only 1 and 3 polymerized MMA in a controlled fashion to 
yield polymers with linear molecular weight increases and low dispersities. Polymerization with 
2, 4, and 5 showed constant molecular weight, indicating early termination of the polymer chains 
and even undesired coupling reactions in the case of 5. It has been reported that some ruthenium 
benzylidenes preferentially promote redox-initiated free radical polymerization over ATRP;18 
however, no clear explanation has been put forward to rationalize the differences. The present 
work shows that complexes 1 and 3, which exhibited rapid in situ conversion in CHCl3 with high 
product yield in ATRA, also promoted efficient ATRP. A well-known side reaction of ATRA is 
polymerization/oligomerization, which can proceed via redox-initiated free radical 
polymerization. Thus, the ATRA data can be used to explain which ruthenium benzylidene 
precatalysts favors ATRP over free radical polymerization.  
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Figure 1.1.5. Kinetic studies of ATRP catalyzed by ruthenium benzylidene complexes. (a) 
ln([M]0/[M]t) over time. (b) Mn and Đ over MMA conversion with 1 and 3. (c) Mn and Đ over 
MMA conversion with 2, 4, and 5. 
Conclusion 
We have discovered that, under ATRA conditions, ruthenium benzylidene complexes are 
transformed into one or more new ATRA-active, metathesis-inactive ruthenium species, possibly 
a simple RuxCly(PCy3)z complex. The same complexes that give high yields and minimal 
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competing side reactions in ATRA also promote living ATRP over uncontrolled free radical 
polymerization. The results of this study showcase the importance of mechanistic inquiry as a 
means of better understanding and ultimately improving tandem catalytic reactions. 
Supporting Information 
Detailed experimental procedures, NMR spectra, and computational and crystal data are contained 
in Appendix A.  
Notes 
All experimental work was performed by Lee and Engle. All computational work was performed 
by Grandner. 
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Chapter 1.2 
Metathesis and Decomposition of Fischer Carbenes of Cyclometalated Z-Selective Ruthe-
nium Metathesis Catalysts 
Tonia S. Ahmed,# Jessica M. Grandner,# Buck L. H. Taylor, Robert H. Grubbs, K. N. Houk 
# Equal contribution 
Olefin metathesis has become a favored method for the generation of carbon-carbon double 
bonds. Ruthenium-based catalysts exhibit excellent stability, functional group tolerance, and gen-
eral ease of use.1 Metathesis has been implemented in several fields including green chemistry,2 
organic synthesis,3 materials science,4 and pharmaceuticals.5  
Scheme 1.2.1. Formation of Fischer Carbene Complexes by Reaction of Ethyl Vinyl Ether 
with Olefin Metathesis Catalysts. 
 
Reactions utilizing these catalysts are often quenched by the addition of an excess of vinyl ether.6 
The vinyl ether reacts with the active catalyst to form a Fischer carbene ruthenium complex (2, 
Scheme 1.2. 1). Due to their stabilities, Fischer carbenes of this type are considered metathesis-
inactive. These Fischer carbenes have previously been isolated and structurally characterized.7,8 
While not active under standard metathesis conditions, Fischer carbenes of this type are active at 
elevated temperatures and with specific substrates.9,10 For example, Takahira and Morizawa re-
cently demonstrated the ability of 2, containing the SIMes ligand, to catalyze productive metathe-
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sis using heavily fluorinated olefins, albeit with very low catalyst turnover. The unexpected activ-
ity of these ruthenium complexes is due to the relative thermodynamic stability of the fluoro-
Fischer carbene formed by metathesis, or Fischer carbene exchange, with 2.10 
 
Figure 1.2.1. Prominent Z-selective catalysts. 
In 2011, kinetically Z-selective ruthenium-based catalysts were first reported bearing an 
adamantyl-chelated NHC ligand and pivalate X-type ligand.11  Many analogs have now been syn-
thesized, including the highly active and Z-selective catalysts 312 and 4.13  Mechanistic and de-
composition studies of these types of cyclometalated complexes have been carried out with both 
experiment and theory.14,15 Decomposition of these catalysts proceeds via irreversible insertion of 
the alkylidene into the chelating ruthenium-carbon bond to produce a ruthenium alkyl intermediate 
(5, Scheme 1.2. 2). A subsequent β-hydride elimination reaction gives ruthenium-hydride 6.15  
Reactions using these chelated metathesis catalysts are also quenched by vinyl ethers.16 It 
was expected that the Fischer carbenes derived from the cyclometalated catalysts would of similar 
stability to 2. Fischer carbenes of type 2 can degrade to ruthenium hydrides.9 Ruthenium hydrides 
are known olefin hydrogenation and isomerization catalysts.17 In order to understand the decom-
position and activity of chelated Fischer carbenes, we have studied the reactions of 3 and 4 with 
vinyl ethers and have identified a ruthenium hydride product potentially capable of causing olefin 
isomerization. Computations were used to explore the decomposition and, surprisingly, we have 
found that metathesis with the Fischer carbene is an integral part of the decomposition pathway. 
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Scheme 1.2.2. Decomposition Pathway of Cyclometalated Ruthenium Catalysts14,15 
 
The reactions of phenyl vinyl ether with chelated catalysts 3 and 4 were performed in THF-
d8 and monitored with 1H NMR. Generation of species thought to be a Fischer carbene was ob-
served by the appearance of a peak shifted upfield with respect to the alkylidene.9 Subsequent 
formation of a hydride species was observed by the appearance of 1H NMR signals at -12.16 ppm 
and -11.97 ppm, respectively, consistent with chemical shifts of known ruthenium hydrides.15 Full 
assignment of the structure by NMR spectroscopy was challenging due to significant overlap of 
aromatic 1H and 13C signals. Consequently, the reaction of butyl vinyl ether with 3 in THF-d8 was 
studied in order to facilitate analysis of the complex by NMR spectroscopy. The reaction mirrored 
the results obtained using pheny vinyl ether. The disappearance of the signal corresponding to the 
benzylidene proton of 3 and the appearance of a broad peak at 13.83 ppm was observed, consistent 
with previously reported Fischer carbenes.9 The subsequent disappearance of this signal and con-
current appearance of a new signal at -12.62 ppm indicated the formation of the hydride species 7 
(Figure 1.2.2).   
 
Figure 1.2.2. Structure of ruthenium hydride, 7.  
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In the 1H-NMR spectrum of this reaction mixture, a singlet corresponding to a single proton 
appears at 5.12 ppm, consistent with that of the alkene proton of known beta-hydride decomposi-
tion products of Z-selective catalysts.15 1H-13C HMBC studies show correlations between the meth-
ylenes of the butyl group to the aforementioned alkenyl singlet at 5.12 ppm, which furthermore 
shows correlations with the protons of the adamantyl group. 13C-DEPT experiments showed the 
existence of 4 methyl groups, 10 methylene groups, 6 methine groups, 7 quarternary carbons in 
the structure of this complex. High-resolution mass spectrometry confirmed the mass correspond-
ing to 7.  
Scheme 1.2.3. Isomers of Fischer Carbene and Respective Hydrides 
 
Density functional calculations were performed to determine the decomposition pathways 
available to Fisher carbenes derived from complex 3. Reaction of 3 with phenyl vinyl ether leads 
to formation of Fisher carbene 8. However, 8 cannot lead to the observed product 12 via migratory 
insertion and β-hydride elimination.15 Figure 1.2.3 is a top view of 8 and the subsequent insertion 
intermediate, 9. The β-hydrogen of 8, highlighted in green, is on the same side as the Fischer 
carbene and far from the ruthenium center. After migratory insertion of the carbene to 9, the β-
hydrogen is pushed even further from the ruthenium center, to a distance of 3.84Å. The structural 
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images in Figure 1.2.3 show that the highlighted hydrogen is not activated for elimination due to 
this distance.  Therefore, diastereomer 8 is prevented from direct degradation to the observed prod-
uct 12. DFT results (Figure B.S17) indicate that migratory insertion followed by alpha-hydride 
elimination could occur to give 10 with a rate-determining step of 25.5 kcal/mol. This product has 
not been observed experimentally. 
 
 
Figure 1.2.3. View of 8 and 9, looking down on the NHC. β-hydrogen highlighted in green. 
Therefore, there must be an alternative, lower energy path to decomposition of 8 to the 
experimentally observed 12. Based on the recent literature on Fischer carbene exchange,10 we pro-
pose epimerization of Fisher carbene 8 to 11 via metathesis with excess vinyl ether.18 Complex 11 
could then decompose to experimentally observed hydride 12 via the pathway previously reported 
and shown in Scheme 1.2.2. 
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Figure 1.2.4. Metathesis of Fischer carbene 8 with phenyl vinyl ether to form the thermodynamically 
more stable diastereomer 11’.
The free energy surface for Fischer carbene exchange is shown in Figure 1.2.3.  The [2+2] cy-
cloaddition of 8 with phenyl vinyl ether has a barrier of only 14.2 kcal/mol to form metallacycle 14. 
Isomerization of 14 to 15 followed by retro-[2+2] via 16-TS leads to the new diastereomer 11. Carbene 
rotation leads to the more stable 11’. Calculated barriers for the homodimerization of olefins with catalyst 
3 and analogues range from ~11-15 kcal/mol and are comparable to the barrier for Fischer carbene ex-
change.14,19 Metathesis with 8 with vinyl ethers is therefore both kinetically and thermodynamically fea-
sible.  
The decomposition pathways of 11 and 11’ were also calculated (Figure 1.2.4). Decomposition of 
11 leads to the more thermodynamically stable hydride and is shown in Figure 1.2.5.20 Carbene insertion, 
via 17-TS, has a barrier of 25 kcal/mol. This barrier is similar to that reported in the carbene insertion of 
benzylidene 3. β-hydride elimination from 18 is nearly barrierless and leads directly to hydride 12, with 
the vinyl ether acting as a chelating π-ligand.  
27 
 
Experiments with 0.1 equivalents of butyl vinyl ether and 1 equivalent of catalyst lead to quanti-
tative conversion to hydride. This result is consistent with our predicted metathesis-dependent decompo-
sition pathway if formation of 8, or initiation, is slower than Fischer carbene exchange of 8 to 11. Wang 
et al. previously computed initiation of 3 with styrene. The rate limiting step of the initiation is the retro-
[2+2] to form the free Hoveyda chelate. The computed barrier for this transition state for reaction of 3 
with phenyl vinyl ether is 23.4 kcal/mol. Therefore, initiation is significantly slower than carbene ex-
change. During the degradation process, a small portion of the catalyst will be initiated to 8/8’ and subse-
quently converted to 11/11’ via fast exchange and regenerate an equivalent of vinyl ether.  
 
Figure 1.2.5. Decomposition of Fischer carbene 11 to hydride 12.    
Computations and experiment support the decomposition of the cyclometalated Fischer carbenes 
to hydrides and show that Fischer carbenes are not inert to metathesis if a Fischer carbene of similar 
stability can be generated. These results have an important impact for future use of vinyl ethers to quench 
reactions involving cyclometalated Z-selective catalysts. When a vinyl ether is used to quench a metath-
esis reaction, ruthenium hydrides can form rapidly in the reaction mixture if the Fischer carbene is not 
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separated promptly. The presence of hydrides can potentially lead to degradation of the Z-olefin content 
or to olefin walking.    
In conclusion, we have demonstrated that Fischer carbenes can be formed from reactions of vinyl 
ethers with cyclometalated Z-selective ruthenium metathesis catalysts. These Fischer carbenes degrade to 
ruthenium hydrides rapidly under the reaction conditions as shown by 1H NMR experiments. We have 
also shown that Fischer carbenes such as 8 and 11 are not metathesis inactive if carbenes of similar sta-
bility result.  The mechanism of the decomposition has been elucidated by DFT. Experiments to determine 
how these hydrides affect internal olefins are currently underway.  
Supporting Information 
Experimental procedures, detailed NMR studies, and additional computational details are available in 
Appendix B. 
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Chapter 2.1 
The Origins of the Stereoretentive Mechanism of Olefin Metathesis with Ru-Dithiolate 
Catalysts 
Jessica M. Grandner, Huiling Shao, Robert H. Grubbs, Peng Liu, K. N. Houk 
Introduction 
Since the advent of olefin metathesis catalysts, control of product olefin stereochemistry 
(Figure 2.1.1) has been an elusive goal. In the cross-metathesis of two alkenes, E-olefins are 
frequently obtained as the major product due to the thermodynamic preference for E- over Z-
isomers. This thermodynamic favoring of E-olefin formation often leads to only moderate 
selectivity that varies from product to product, exemplified by ring-closing metathesis.1 Thus, 
kinetic control of olefin stereochemistry is highly desirable. Recently, catalysts have been 
developed that favor kinetically the formation of thermodynamically unfavorable Z-olefins with 
>95% selectivity. These catalysts have been successfully applied to various Z-selective metathesis 
reactions including cross-metathesis, ring-closing metathesis, ring-opening cross-metathesis 
(ROCM) and ring-opening metathesis polymerization (ROMP).2 However, ruthenium-based 
catalysts that provide the same high kinetic selectivity for formation of E-olefins have not yet been 
developed.3 In 2013, Hoveyda and coworkers synthesized dithiolate ligated Ru-based catalysts 
that demonstrated high Z-selectivity in ROCM and ROMP.4 Their computational studies revealed 
ring-opening cross metathesis via a side-bound mechanism that kinetically favors formation of Z-
olefins. They subsequently demonstrated the ability of these catalysts to perform Z-selective cross 
metathesis of acyclic olefins.5  
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Figure 2.1.1. Models of stereoselective olefin metathesis (other work) and stereoretentive olefin 
metathesis (this work). 
In 2016, a series of ruthenium-based dithiolate catalysts, 1-4 in Figure 2.1.2a, were 
synthesized and tested by the Grubbs laboratory.6 These complexes were able to catalyze the cross-
metathesis of internal olefins with retention of starting olefin stereochemistry. Z-olefins were 
selectively converted to new Z-olefins while E-olefins were selectively converted into new E-
olefins.6 This stereoretentive transformation provided the first example of kinetically controlled E-
selective olefin cross-metathesis with Ru-based catalysts. 
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Figure 2.1.2. (a) Catalysts examined by the Grubbs group for stereoretentive metathesis; (b) 
Models for stereoretentive metathesis with Z-olefins (purple) and E-olefins (blue).  
The report from Grubbs examined the reactivity and selectivity of these catalysts to form E-
olefins.6 While catalyst 1 showed low yields for most cross-metathesis reactions with E-internal 
olefins, the reactions produced new products with complete retention of the starting olefin 
stereochemistry (Table 2.1.1). The yields of cross-metathesis reactions were improved by altering 
the NHC structure to that of catalyst 4.6 While the yields are modest, the >99:1 selectivity of 4 for 
stereoretention with E-alkenes is unprecedented. The proposed model that explains the retention 
of stereochemistry is shown in Figure 2.1.2b. For these dithiolate containing catalysts, a side-
bound mechanism is proposed.4,7 Therefor, the plane of the metallacycle (in the 
ruthenacyclobutane intermediate) is perpendicular to the NHC ligand and the substituents at the α- 
and α’-positions of the metallacycle are forced down to avoid steric repulsions with the N-aryl 
groups. Due to these ligand-metallacycle steric interactions, if a Z-olefin reacts, the substituent at 
the β-position also points down (i.e. away from the NHC) and a new Z-olefin is generated. If an 
E-olefin reacts, the substituent at the β-position points up and a new E-olefin is generated.  There 
is presumably no intrinsic preference for the β-substituent to be up or down based on this model. 
Table 2.1.1. Stereoretentive Cross-Metathesis Using Ruthenium Catalysts 1 and 4.6 
 
Stereochemistry 
of Starting Olefin 
Catalyst Yield 
Product 
E:Z 
Z 1 55% <1:99 
E 1 7% >99:1 
Z 4 42% <1:99 
E 4 19% >99:1 
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We examined the origins of stereoretentive metathesis with catalyst 4 using computational 
methods. We have probed the ligand effects on stereoselectivity and examined the steric 
environment of the NHC ligand and the steric repulsions of the NHC ligand with substituents at 
both the - and -positions of the metallacycle. Since catalyst 4 is a promising prototype of a 
kinetically E-selective catalyst, these computational insights can assist in the design of a kinetically 
E-selective metathesis catalyst.  
Computational Methods 
All calculations were performed using Gaussian 09.8 Geometry optimizations and 
frequency calculations were performed at the B3LYP9 level using LANL2DZ for ruthenium and 
6-31G(d) for all other atoms. Zero point vibrational energies, thermal corrections, and entropies 
were computed from frequency calculations with a standard state of 298 K and 1 atm. 
Quasiharmonic oscillator approximations were used to compute the entropic contributions to the 
Gibbs free energies, as discussed by Truhlar.10 Single point energy calculations were performed at 
the M0611 level using SDD for ruthenium and 6-311+G(d,p) for other atoms with the SMD12 
continuum solvent model for THF.  
Results and Discussion 
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Figure 2.1.3. Possible mechanistic pathways for reactions of 5 with butene. 
Our first goal was to determine if the metathesis with catalyst 4 proceeds through a bottom-
bound mechanism, in which the olefin approaches trans to the NHC ligand, or a side-bound 
mechanism, in which the olefin approaches cis to the NHC (Figure 2.1.3).Error! Bookmark not defined.a,513 
While Hoveyda and coworkers explored the side-bound mechanism in references 4a and 5,  a direct 
comparison of the bottom-bound and side-bound mechanisms has not been performed for this class 
of catalysts. Using 5 as a model for the active ethylidene complex of catalyst 4, and E- and Z-
butene as substrates, we calculated all isomeric transition states for both bottom-bound and side-
bound mechanisms. A graphical representation of the computed activation free energies is shown 
in Figure 2.1.4. In all cases, the side-bound transition states (blue) are lower in energy than the 
bottom-bound transition states (red). To adopt a bottom-bound mechanism, the ortho-dithiolate 
ligand must orient one of the sulfur atoms trans to the alkylidene. Such geometry is strongly 
destabilized due to trans-influence of the thiolate on the alkylidene.14 A large distortion of the 
ligand sphere is also required to accommodate the incoming olefin in the bottom-bound 
mechanism. In typical bottom-bound metathesis transition states (e.g. with the second generation 
Grubbs catalyst),15 the alkylidene prefers to be positioned directly under the N-alkyl group. In the 
bottom-bound transition states (5Db and 5Fb), the Cipso−N−Ru−Calkyliene dihedrals (red-
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highlighted atoms in 5Db and 5Fb) are >50⁰. The bottom-bound pathway is disfavored in all cases 
due to a combination of trans influences and steric effects. 
 
Figure 2.1.4. (A) Barriers to formation of ruthenacyclobutane (TS1). There are 2 retention 
pathways (E-to-E and Z-to-Z) and 2 inversion pathways (E-to-Z and Z-to-E) which are represented 
on the X-axis. Each pathway has 4 possible approaches, 2 side-bound (blue columns) and 2 
A 
B 
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bottom-bound (red columns). (B) Transition structures of the 4 approaches for E-to-E metathesis. 
Side-bound pathways (5D and 5F) are shown on the top while bottom-bound pathways (5Db and 
5Fb) are shown on the bottom. 
In the favored side-bound pathway, Figure 2.1.4 shows that the stereoretentive pathways 
for both E- and Z-olefins are lower in activation free energy than the corresponding stereoinversion 
pathways by >3-6 kcal/mol. For the reaction of Z-butene with 5, the preferred mode of addition is 
to have all substituents on the forming metallacycle pointing down, away from the sterically 
demanding NHC (5A, Figure 2.1.5). After the retro-[2+2] cycloaddition of the trisubstituted 
metallacycle, this process leads to retention of the starting Z-olefin stereochemistry. As shown in 
Figure 2.1.5, the two possible pathways leading to E-butene both require much higher activation 
energies.  If the Z-butene adds with both substituents “up” (5C), this costs an additional +3.5 
kcal/mol compared to 5A and induces significant steric repulsion between the N-aryl substituent 
on the NHC and the ɑ’ substituent on the forming metallacycle. The left N-aryl group must distort 
out of the way of the incoming alkene. If the olefin adds “down” and the alkylidene is pointing up 
(5B), there is a +5.2 kcal/mol activation free energy penalty compared to 5A due to the direct steric 
clash of the alkylidene with the N-aryl group, evidenced by the short distance between the H atom 
on the alkylidene and the ortho-F atom on the NHC N-aryl group (2.29 Å). Due to these steric 
penalties, the retentive pathway is strongly favored, leading to exclusive formation Z-olefins.  
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Figure 2.1.5. [2+2] cycloaddition (5A-C) and retro-[2+2] cycloaddition (5A’-C’) transition 
structures and ruthenacyclobutane intermediates (5Am-5Cm) and respective Gibbs free energies 
of activation for the lowest energy Z-retentive pathway (A) and 2 possible stereoinversion 
pathways (B, C) for the reaction of 5 with Z-butene. All energies are Gibbs free energies in 
kcal/mol with respect to the separated reactants 5 and Z-butene. The other Z-retentive pathway 
with all three metallacycle substituents pointing up requires much higher activation energy (∆G‡ 
= 20.4 kcal/mol) and is not shown.  
 In the reaction with E-olefin, at least one substituent on the forming metallacycle must 
point up towards the NHC. The least sterically demanding position for a substituent to point up 
towards the NHC is the β-position of the forming metallacycle (shown in blue spheres in Figure 
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2.1.2b). Figure 2.1.6 shows the computed reaction pathways for E-butene. The lowest energy 
pathway (5D) is one in which there is only one substituent, at the β-position, points towards the 
NHC and leads to retention of olefin stereochemistry. Due to similar steric effects as in the 
reactions with Z-olefins, pointing the alkylidene up (5C’) or reversing the olefin approach (5B’) 
incurs activation free energy penalties. This leads to a 6.0 kcal/mol preference for retention and 
exclusive formation of a new E-olefin when reacting with an E-olefin.  
 
Figure 2.1.6. [2+2] cycloaddition (5D, 5B’, 5C’) and retro-[2+2] cycloaddition (5D’, 5B, 5C) 
transition structures and ruthenacyclobutane intermediates ( 5Dm, 5Bm, 5Cm) and respective 
Gibbs free energies of activation for the lowest energy E-retentive pathway (D) and 2 possible 
stereoinversion pathways (B, C) for the reaction of 5 with E-butene. All energies are Gibbs free 
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energies in kcal/mol with respect to the separated reactants 5 and E-butene. The other E-retentive 
pathway with the α and α’ substituents of the metallacycle substituents pointing up requires a much 
higher activation energy (∆G‡ = 21.7 kcal/mol) and is not shown.  
 The analysis of transition state isomers in Figure 2.1.6 revealed the design principles for 
E-selective metathesis catalyst: the N-aryl substituents on the NHC ligand should maximize the 
steric repulsions with the ɑ-substituent on the metallacycle while still allowing the β-substituent 
to point up towards the NHC ligand. Thus, a few factors, including the steric properties of the N-
aryl group as well as the NHC backbone substituents, are expected to affect the E/Z selectivity. To 
gain deeper insights into the steric environment of the NHC ligand and the steric interactions with 
the olefin and alkylidene substituents, we plotted the 2D steric contour maps16 of catalyst 4. The 
ligand steric contour map is derived from the van der Waals surface of the NHC ligand from the 
optimized structures of the ethylidene complex 6 and the lowest-energy ruthenacyclobutane 
intermediates 6Dm and 6Am in the lowest energy E- and Z-retentive pathways, respectively. The 
contour map was created following the previously reported procedure.16g The NHC ligand is 
rotated and translated so that the Ru atom is placed at the origin of the Cartesian coordinate system 
and the z-axis is oriented along the Ru−C(carbene) bond. The contour line of zero is drawn through 
all points on the van der Waals surface having the same z coordinate as the Ru atom. The positive 
contour lines (colored in green and blue) indicate regions on the ligand van der Waals surface 
having a positive z coordinate, i.e. more distant from the plane of the ruthenacyclobutane. Yellow 
and red indicate regions closer to the ruthenacyclobutane where more significant ligand-substrate 
steric clashes are expected. 
 To examine the conformational change of the NHC ligand along the E- and Z-retentive 
pathways, steric contour maps of the same NHC ligand in the ethylidene complex 6 and the two 
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ruthenacyclobutanes featuring a “down-up-down” (6Dm) and “down-down-down” (6Am) 
substitution patterns on the metallacycle are plotted in Figure 2.1.7. In ethylidene complex 6, one 
of the N-2,6-difluorophenyl groups is significantly tilted due to flexibility of the N-aryl bond.17 
This tilted N-aryl conformation creates a relatively sterically demanding pocket between the two 
ortho-F substituents (see the red and orange regions near the “closed” pocket on the contour map 
of 6). In the metallacycle intermediates, the N-aryl group rotates away from the metallacycle, as 
indicated by the disappearance of the red and orange regions on the contour plot. This 
conformational change creates a much larger “open” pocket between the two ortho-F substituents 
to accommodate the β-substituent. To our surprise, the ligand conformation in 6Dm and 6Am are 
remarkably similar. The “open” pocket above the β-substituent is present regardless if the β-
substituent is pointing up or down. A closer inspection of the geometries of the metallacycles 
revealed that the N-aryl groups in both 6Dm and 6Am are slightly tilted away from the 
metallacycle due to the steric repulsions with the hydrogen atoms at the ɑ- and ɑ’-positions. This 
steric effect also distorts the NHC ligand towards the dithiolate: the S−Ru−C(carbene) bond angle 
is decreased from 94.8º in ethylidene 6 to 87.7º and 86.8º in 6Dm and 6Am respectively. This 
distortion also contributes to the formation of the “open” pocket above the β-substituent in 6Dm 
and 6Am. Due to the formation of this “open” pocket, the steric repulsions between the NHC 
ligand and the β-substituent in 6Dm are diminished. The “down-down-down” isomer 6Am 
becomes 3.6 kcal/mol less stable than the “down-up-down” isomer 6Dm because of the repulsion 
between the adjacent methyl groups on the metallacycle in 6Am.  
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Figure 2.1.7. Ligand steric contour maps of (a) ethylidene complex 6, ruthenacyclobutane 
intermediates (b) 6Dm and (c) 6Am. The open pocket above the β-Me substituent promotes both 
E- and Z- retentive pathways. 
We also investigated the origin of the reactivity difference between catalysts 1 and 4 in the 
Z- and E-retentive metathesis. In these studies, we used the complete NHC ligand for catalyst 4 
with the germinal dimethyl substituted backbone (as in 6). The rate-limiting transition states for 
E-retentive 
ΔΔG = 0.0 kcal/mol 
Z-retentive 
ΔΔG = 3.6 kcal/mol 
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the Z- and E-retentive pathways of both catalysts are shown in Table 2.1.2. The rate-limiting steps 
for both pathways are more than 2 kcal/mol lower in activation free energy with catalyst 4 (6A & 
6D) than with 1 (7A & 7D), suggesting 4 is a more reactive catalyst in reactions with both E- and 
Z-olefins. The lower reactivity of 1 is due to the presence of the more hindering ortho-methyl 
groups of the SIMes ligand which cause more steric repulsion with the incoming olefins than the 
ortho-F groups on catalyst 4.  
Table 2.1.2. Rate-limiting transition structures for the retention pathways with catalysts 4 and 1.  
 
To examine the ligand steric environment in catalyst 1, we plotted the steric contour maps 
of the active alkylidene complex 7 and ruthenacyclobutane intermediates 7Dm and 7Am in the E- 
and Z-retentive pathways (Figure 2.1.8). The steric contour maps show that, similar to the reactions 
with complex 6 in Figure 2.1.7, an “open” pocket is created above the β-substituent in both 
ruthenacyclobutane intermediates 7Dm and 7Am. Again, the formation of this open pocket is due 
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to the steric repulsions with the hydrogen atoms at the ɑ- and ɑ’-positions of the metallacycle. 
Compared to the ortho-F substituted catalyst 1, the ortho-Me groups on catalyst 4 lead to greater 
repulsions with the metallacycles in both 7Dm and 7Am. This is evidenced by the greater 
distortion of the NHC ligand towards the dithiolate: the S−Ru−C(carbene) bond angle is 84.2º and 
83.2º in 7Dm and 7Am, respectively, even smaller than the S−Ru−C(carbene) angle in 6Dm and 
6Am (87.7º and 86.8º, respectively). These results are in agreement with transition structures 
above that catalyst 1 is highly E- and Z-retentive due to the open pocket above the β-position on 
the metallacycle. However, the reactivity of catalyst 1 is lower than that of 4 due to stronger steric 
repulsions with the metallacycle in the side-bound pathways.  
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Figure 2.1.8. Ligand steric contour maps of (a) ethylidene complex 7, ruthenacyclobutane 
intermediates (b) 7Dm and (c) 7Am.  
Conclusion 
 In conclusion, we have performed computational studies on the stereoretentive olefin 
metathesis using dithiolate-ligated ruthenium catalysts 1 and 4 to understand their reactivity and 
selectivity in the cross-metathesis with E- and Z-olefins. We have confirmed that the substituents 
at the α-positions of the forming metallacycle prefer to point away from the NHC ligand, while 
E-retentive 
ΔΔG = 0.0 kcal/mol 
Z-retentive 
ΔΔG = 3.0 kcal/mol 
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the -substituents may point either away or towards the NHC without incurring significant steric 
clashes with the NHC ligand, as proposed by Grubbs and co-workers.6 These ligand-controlled 
steric interactions enforce the retention of the original olefin stereochemistry in metathesis. DFT-
optimized transition structures and ligand steric contour maps revealed the important role of the 
steric interactions between the NHC ligand and the hydrogen atoms at the α- and α’-positions of 
the metallacycle. Such interactions tilt the N-aryl group on the NHC ligand and create an “open” 
pocket above the -position of the metallacycle, which can accomdate a substituent pointing 
towards the NHC ligand. This “open” pocket is critical for the stereoselectivity in the E-retentive 
metathesis. The DFT calculations also revealed the effects of ligand-metallacycle steric 
interactions on reactivity. The N-mesityl substituted catalyst 1 is slightly less reactive than the 2,6-
difluorophenyl substituted catalyst 4 due to the unfavorable steric repulsions between the bulkier 
N-mesityl groups and the metallacycle in the side-bound metathesis pathway.  
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Chapter 2.2 
Design of a Kinetically E-Selective Metathesis Catalyst 
We have built on the results from our computational investigation into the stereoretentive 
metathesis catalysts in Chapter 2.1 to design a catalyst which disfavors metathesis with Z-olefins 
while facilitating metathesis with E-olefins. We’ve shown that the bis(dithioloate) ligand forces a 
side bound mechanism which is critical for stereoretention. The Grubbs group hypothesized that 
adding steric bulk to the bis(dithiolate) would enforce stereoretentive metathesis but block 
interaction with Z-olefins. They synthesized phenanthrene- and napthalene-based bis(dithiolate) 
ligands with the goal of having the arene point into the β position of the forming metallacycle.1 
The ligands, catalysts, and metallacycle model are shown in Figure 2.2.1.  
 
Figure 2.2.1. Structures of dithiolate ligands and the metallated catalysts. The model proposed for 
the metallacycle is shown in the box. 
Once metallated, NMR spectra revealed that two isomers of the catalysts had been formed. 
These isomers are the possible ligation modes of the thiolate, arene down or arene up (Figure 
2.2.2). Based on the NMR results, there is a ratio of 2.8:1 ratio for catalyst 4 and a 1.5:1 ratio for 
catalyst 5, but the favored isomer of each catalyst was unknown.1 We performed computational 
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studies2 of the conformers of 4 and 5 to determine which conformer is favored and the likelihood 
that this catalyst would induce E-selective metathesis.  
 
Figure 2.2.2. Stereoisomers of catalyst 4. 
The computed structures of catalyst 4 are shown in Figure 2.2.3A. The up conformer is 
favored by 0.8 kcal/mol. This equates to a up:down ratio of 3.4:1 which is very consistent with the 
experimental ratio of 2.8:1. The computed structures of catalyst 5 are shown in Figure 2.2.3B. The 
up and down conformers are isoenergetic and lead to a 1:1 ratio which is consistent with the 
observed 1.5:1 ratio. These computations indicate that the predominant catalyst isomer is the up 
isomer which does not impose any steric influence on the face of the catalyst which performs 
metathesis.  
A front view of 5-down is shown in Figure 2.2.4.  The methyl substituent is far from the 
isopropyl group of the Hoveyda chelate and indicates that even the down isomer of the catalyst 
would impose little-to-no steric influence on the β position of a metallacycle. To test this, we 
optimized an unsubstituted metallacycle of 5-down (5-mcb in Figure 2.2.4). As shown in 5-mcb, 
the methyl group is too far from the ‘active site’ of the catalyst to impose a steric influence on the 
metallacycle.  
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Figure 2.2.3. A. 3D side views of 4-down (left) and 4-up (right); B. 3D side views of 5-down 
(left) and 5-up (right) with relative free energy difference indicated in 2D structures (arrows in 2D 
indicate the point of view in 3D images). 
 
Figure 2.2.4. Front view of catalyst 5-down and side view of the metallacycle 5-mcb. 
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Through these computations, it is clear that substituents on dithiolate ligands are too remote 
to have an influence on metallacycle formation. Alternatively, if the nature of the thiolate could be 
altered to have a substituent directly off the axial, X-type ligand, this substituent may be close 
enough to the forming metallacycle. This thought process is illustrated in Figure 2.2.5.  
 
Figure 2.2.5. Schematic for design of E-selective catalysts. On the left is a side view of metathesis 
with Z-butene with dithiolate ligand from Chapter 2.1. The top and bottom of the metallacycle 
plane are open, allowing for metathesis with Z-olefins. On the right is an image of a catalyst with 
a new x-type ligand which has a substituent pointing directly into the bottom plane of the 
metallacycle. This may block metathesis with Z-olefins but allow for metathesis with E-olefins. 
We obtained a list of synthesizable benzenediamine-based ligands shown in Figure 2.2.6. 
The computed the barriers to metallacycle formation (TS1) for E-to-E metathesis and Z-to-Z 
metathesis with each ligand are shown in Table 2.2.1. As with the dithiloate ligands, NHC4 is 
predicted to perform faster metathesis than NHC1. For amines without conformational flexibility, 
such as amine2, TS1 (2+2) and TS2 (retro-2+2) are the same. Amine1 and amine2 were designed 
to be similar in structure to the dithiolate ligands in Chapter 2.1. Amine3 through amine5 were 
designed to reduce the basicity of the amines and avoid undesired catalyst decomposition.3 While 
amine2 is conformationally rigid at the nitrogen substituent, amine3 through amine5 have 
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different conformations which could be access during catalysis. These conformations examined 
for each amine and the lowest energy conformations of TS1 are given in Table 2.2.1. Although the 
combination of NHC4 and amine5 appears promising, the Grubbs group was unable to metallate 
amine5.  
 
Figure 2.2.6. NHC and amine ligands examined for E-selective metathesis with computations.  
Table 2.2.1. Barriers to stereoretentive metathesis with NHC diamine ligand combinations 
NHC/Amine combination E-to-E TS1 Z-to-Z TS1 
NHC1/Amine1 29.0 27.1 
NHC4/Amine1 20.0 20.6 
NHC1/Amine2 15.1 17.3 
NHC4/Amine2 12.7 14.9 
NHC1/Amine3 19.1 21.1 
NHC4/Amine3 13.6 18.4 
NHC4/Amine4 12.9 16.4 
NHC4/Amine5 7.8 11.7 
 
53 
 
 
Figure 2.2.7. Transition structures with rigid amine ligands (left) and flexible amine ligands 
(right). 
While many factors may have caused the unsuccessful metalation of amine5, the bulkiness 
of the nitrogen substituents that were designed to reduce basicity could be hindering metalation. 
We then designed new ligands shown in Figure 2.2.8, which contain functional groups that are 
able to reduce the basicity of the nitrogens but are not bulky and flexible. The ligands we designed 
incorporated aromaticity and carbonyls in the backbone of the ligand rather than on the N-
substituents. Table 2.2.2 shows the results of the DFT metathesis calculations. amide1 and amine6 
are predicted to have good E-selectivity and reasonable barriers to metallacycle formation. 
Alternatively, the methylene linker of amine7 caused the pyrroles to adopt a distorted binding 
pose compared to amine6 and thus caused an increase in barriers to metallacycle formation. As a 
result of these computational results, the Grubbs group is currently attempting to metallate amide1 
and amine6 in combination with commercially available NHC1.  
 
Figure 2.2.8. Second round of amine/amide ligands designed for E-selective metathesis. 
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Figure 2.2.9. Transition structures for E-to-E metathesis with NHC1/Amine6 and 
NHC1/Amine7. The methylene spacer of amine7 forces improper ligation of the nitrogens. 
Table 2.2.2. Barriers to stereoretentive metathesis with NHC diamine ligand combinations 
NHC/Amine Combination E-to-E TS1 Z-to-Z TS1 
NHC1/Amide1 17.1 18.6 
NHC4/Amide1 12.8 15.3 
NHC1/Amine6 10.7 12.7 
NHC1/Amine7 19.1 21.6 
In conclusion, we have used computations to identify two di-nitrogen ligands, amide1 and 
amine6, which are predicted to facilitate E-selective cross metathesis. In doing so, we have 
identified characteristics of di-nitrogen ligands. The ligand needs to contain functional groups that 
reduce the basicity of the nitrogens, such as carbonyls or aromatic groups. The ligand also needs 
to be rigid and not contain large groups as nitrogen substituents. 
Supporting Information 
Additional spectral data and computational information is provided in Appendix C. 
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Chapter 3.1 
Studying the Substrate Specificity and Reactivity of MycG: A Multifunctional Enzyme 
P450 enzymes catalyze a wide array of reactions including, but not limited to, 
hydroxylation, epoxidation, C-C coupling, N-dealkylation, sulfoxidation, and arene oxidation.1 
While enzymes have evolved to catalyze reactions with excellent selectivity and efficiency, a few 
are able to catalyze multiple oxidative steps involving separate reaction mechanisms.2 MycG is 
one such enzyme which catalyzes the sequential hydroxylation and epoxidation of M-IV to M-II. 
The order of these oxidative steps is critical. M-I is a side product in which the epoxide is installed 
first. If M-I is fed back to MycG, no hydroxylation to M-II is observed.3  
Scheme 3.1.1. MycG catalyzed oxidation of M-IV.  
 
In addition to selectively performing 2 sequential and distinct oxidative steps, MycG is highly 
substrate specific. M-IV, M-III, and M-VI are identical in macrocyclic structure and differ only 
in extent of methylation of the mycinose sugar moiety. Despite having ≥110 atoms in common, 
>94% identical to M-IV, M-III and M-VI experience very low levels of oxidation when tested 
with MycG. Based on LC-MS and MS-MS data, it is believed that these minor products are 
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hydroxylation of the respective macrocycles but the exact structure of the oxidized products could 
not be determined since there was such a small amount of product formed.3 
 
Figure 3.1.1. Macrocycles in the biosynthesis of M-II which differ in the extent of methylation 
of deoxysugar at C14. Only M-IV is effectively oxidized by MycG. 
We set out on a computational investigation of the profound substrate selectivity and reactivity 
preferences of MycG. Molecular dynamics (MD) simulations and MetaDynamics were used to 
determine how these minor differences in the sugar at C14, remote from the sites of oxidation, 
have an impact on activity. Molecular dynamics were performed by Song Yang in the Houk group 
and will not be discussed in this dissertation. To determine why the order of oxidation of M-IV is 
so critical, we used density functional theory (DFT) calculations. Collectively, these methods 
complement each other to fully understand this complex, multi-functional enzyme.  
Computational Methods 
Quantum Mechanics. DFT calculations were performed using the Gaussian09 suite.4 
Conformational sampling of substrates and transition states were performed using Spartan.5 The 
default settings for conformer distribution calculations were used. For transition states, the OFe-
Hsubstrate and Hsubstrate-Csubstrate bonds and were frozen and other substrate torsions were sampled, 
including rotation about the C-H bond being abstracted. Due to the large number of conformers of 
each substrate and transition state, the iron-oxo model and transition structures were computed at 
the quartet spin state. Geometry optimizations and frequency calculations were performed at the 
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B3LYP level.6 The 6-31G(d) basis set was used on all atoms except Fe, for which the LANL2DZ 
pseudopotential was used. Saddle point transition structures were confirmed by the presence of 
one imaginary frequency corresponding to the desired transformation. Thermal corrections were 
computed at 1 atm and 298.15 K. The quasi-harmonic correction, as described by Truhlar, was 
used to adjust the Gibbs free energy.7 Single point calculations were performed at the B3LYP-
D3(BJ)8 level with CPCM9 implicit solvation for water. LANL2DZ was used for Fe and 6-
311+G(d,p) was used for all other atoms.    
Results and Discussion 
 
Figure 3.1.2. Model reaction used to study the activity of MycG with DFT. 
Using A as a model for M-IV and B as a model for M-I, we performed density functional 
calculations to determine the barriers to C-H abstraction. With respect to separated reactants, the 
free energy barrier to C-H abstraction from A (A-TS) is 14.6 kcal/mol. The barrier to abstraction 
from B (B-TS) is 20.1 kcal/mol. This 5.5 kcal/mol increase for B-TS means that abstraction from 
the epoxidized substrate is 10,000 times slower than A-TS. This drastic difference in activity is in 
accord with the lack of activity toward M-I. The presence of the epoxide in M-I decreases the 
inherent reactivity, so that MycG is unable to hydroxylate this intermediate.  
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Figure 3.1.3. Free energies and transition structures of the C-H abstraction from A and B. 
There are 2 attributes of the installed epoxide which could destabilize the developing 
radical and be the origin of the barrier increase: 1) the lack of allylic stabilization; 2) the electron-
withdrawing nature of the oxygen. To probe these two properties of the epoxide independently we 
computed the barriers to C-H of two additional substrate models. Model C mimics the electron 
withdrawing nature of the oxygen in M-I but still has the conjugation present as in M-IV. Model 
D mimics the loss of conjugation due to the epoxide but no electron withdrawing groups are 
present. The barriers to C-H abstraction from C and D are 15.9 (C-TS) and 18.9 (D-TS) kcal/mol, 
respectively. In comparison to A-TS, the barrier increases by +1.3 kcal/mol for C-TS and +4.3 
kcal/mol for D-TS. Both factors therefore contribute to the barrier increase in B-TS, but the lack 
of allylic stabilization is the most significant factor.  
 
 
A-TS B-TS 
60 
 
 
 
Figure 3.1.4. Top: Substrate models C and D; Bottom: ΔG‡[difference from A] for C-TS (left) 
and D-TS (right). 
Conclusion 
We have used multiple computational methods to investigate the selectivity of the multi-functional 
P450 MycG. In the mycinamicin biosynthetic pathway to M-II, M-IV undergoes sequential 
hydroxylation to M-V then epoxidation to M-II.3 Density function theory calculations prove that 
the order of oxidation of M-IV is due to the need for stabilization on the C-H abstraction transition 
state. When the epoxide is installed first, leading to M-I, the presence of the epoxide has removed 
the allylic stabilization of M-IV and is inductively withdrawing. By using substrate analogues, we 
determined that the lack of resonance stabilization of the developing radical is the lead cause of 
the inactivity of MycG towards M-I.  
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Chapter 3.2 
Regiodivergent Cyclization and Biocatalytic C-H Oxidation Enable Synthesis of Diverse 11- 
and 12-Membered Macrolactones from a Single Linear Substrate 
Michael M. Gilbert, Matthew D. DeMars, Song Yang, Jessica M. Grandner, Shoulei Wang, 
Hengbin Wang, Alison R. H. Narayan, David H. Sherman, K. N. Houk, John Montgomery 
In traditional linear synthetic approaches, complexity in a structure is assembled in a 
stepwise manner to obtain a single desired product. In this approach, a new synthesis must be 
devised for each structural analogue. As a method to streamline efficient access to analogues of a 
structural motif, late-stage diversification of an advanced synthetic intermediate often involves the 
interchange of functional groups after a fully functionalized core structure is accessed. A 
disadvantage of this approach is that assembly of the late-stage common intermediate itself often 
requires a lengthy linear synthesis and provides structures that are closely related with an identical 
core framework. An appealing strategy for more substantial late-stage diversification involves 
diversifying the framework itself (1). Through this approach, accessing two or more structural 
frameworks from a single intermediate is typically best achieved through processes such as 
accessing multiple cycloaddition pathways available to a single substrate or through catalyzing a 
thermodynamically driven rearrangement such as transesterification, sigmatropic rearrangement, 
or ring expansion or contraction (2-4). A second attractive strategy for achieving late-stage 
diversification begins from a single core structure followed by installation of various substituents 
on the periphery through site-selective C-H functionalization (5-11). While C-H functionalization 
strategies hold enormous promise, limitations in both site-selectivity and functional group 
compatibility (i.e. alkenes or basic amines) remain a considerable challenge in complex settings. 
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Currently, a significant gap exists in synthetic strategies that involve late-stage scaffold 
diversification combined with a versatile site-selective C-H functionalization approach. By first 
converting a single substrate into two or more molecular scaffolds and then accomplishing site-
selective diversification of each of the obtained structural motifs through C-H functionalization, 
the rapid assembly of highly diverse analogues differing in both the core structural scaffold and 
peripheral functionality would become possible. (Figure 3.2.1A). Such an approach offers the 
simplicity of accessing a linear substrate with minimal functionality as the point of divergence and 
would provide a powerful strategy for the rapid assembly of molecular diversity and complexity. 
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Figure 3.2.1. Approach to late-stage diversification. (A) Conceptual framework for late-stage 
diversification by regiodivergent scaffold assembly followed by site-selective C-H oxidation. (B) 
Regiodivergent reductive macrocyclizations. (C) General strategy for enabling site-selective 
biocatalytic oxidation. 
The focus of this study is to utilize a simple linear ynal as a test substrate for assembly of 
11- and 12-membered macrolactones followed by late-stage, site-selective oxidations to access a 
collection of functionalized macrolide analogues. Preparation of these test substrates by a nickel-
catalyzed reductive macrocyclization process allows access to either regiochemical outcome (i.e. 
endo- or exocyclization) in macrolactone assembly by tailoring the ligand structure and reaction 
conditions (Figure 3.2.1B) (12-13). This regiodivergent catalytic process provides an ideal 
approach for accessing different ring sizes of macrolactone substrates that possess multiple 
unactivated methylene (CH2) groups for exploration of new strategies for site-selective C-H 
oxidation. While impressive strides have been made in strategies that enable site-selective 
oxidations in multi-ring structures with well-defined conformations (14-17), selective access to 
multiple patterns of oxidation in macrocyclic compounds represents a challenge unmet by previous 
approaches. In order to address this limitation, the straightforward modular assembly of an 
enantiopure ynal precursor 1 was followed by regiodivergent and highly diastereoselective 
reductive macrocyclization to afford macrocycles 2 and 3. This approach, governed largely by 
steric properties of the N-heterocyclic carbene (NHC) ligand, enables access to a large array of 
linear and macrocyclic structures through predictable reversals of regiochemistry in the C-C bond-
forming step. 
Macrocyclic substrates 2 and 3 provide a challenging context for developing site-selective 
C-H oxidations on different scaffolds that possess a multitude of similarly reactive C-H bonds. To 
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address this challenge, we examined the utility of an engineered fusion protein of the bacterial 
cytochrome P450 enzyme PikC. In prior work, engineered mutants of the PikC enzyme displayed 
excellent site-selectivity in oxidations of amine-containing substrates closely related to the 
endogenous macrolide substrate YC-17 (18) or of smaller, structurally-compact substrates such as 
simple terpenes (e.g., menthol) (19). However, the conformational flexibility of macrocycles that 
possess six or more methylene groups poses a tremendous challenge in site-selective oxidation 
that has not yet been efficiently addressed by chemical or biological catalysis. With such subtle 
differences in the reactivity of similar methylene groups, the use of directing groups presents the 
best opportunity for achieving tunable site-selectivity. While recent developments in enzyme 
engineering have demonstrated remarkable advances in organic synthesis (20-22), the use of 
substrate engineering as a synergystic approach to achieving site-selectivity in enzymatic 
transformations is greatly underutilized. Structural variations in rigid directing groups have 
recently demonstrated enormous promise in remote C-H functionalizations using small molecule 
catalysts (23-24). Despite pioneering early work from Breslow in designing biomimetic site-
selective functionalizations based on template design (25-26), this approach has not yet been 
developed as a strategy to enable multiple selective outcomes in an enzyme-catalyzed process. 
Previous studies of PikC-catalyzed oxidations illustrated that substrates possessing 
numerous contiguous methylene groups led to unselective oxidation when substrate engineering 
approaches were attempted (27). Thus, although the presence of the aminosugar desosamine is 
essential for binding and selectivity of the PikC enzyme toward its native macrolide substrates, at 
least seven oxidized products were generated when using a desosaminylated, but unfunctionalized, 
twelve-membered macrocyclic substrate. While the use of simple aromatic spacers avoids the 
cumbersome installation of aminosugars (18), we recognized the need for a more versatile strategy 
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that enables an anchoring basic amine to be covalently attached through a linker. The method 
should provide a rapid and high-throughput synthesis, facile length and shape variations of the 
linker component, and efficient chemoselective removal of the linker following C-H oxidation. 
These criteria can all be addressed by the modular connection of hydroxyl-containing substrates, 
amino acid-derived azido acids, and acetylenic amines (Figure 3.2.1C). Through the appropriate 
choice of spacer elements S1 and S2 and access to regiochemistry reversal in azide-alkyne click 
cycloadditions (28-29), a large number of linker structures are readily available. Notably, click 
reactions are typically utilized as a simple means to connect two structures without regard to the 
precise structural features of the linking functionality. However, in our approach, the precise shape 
and geometry of the unit assembled by the azide-alkyne cycloaddition is an integral feature 
required for success of the strategy.  
Derivatives of 11-membered substrate 2 were first examined in the click anchor strategy 
for site-selective biocatalytic oxidation (Table 3.2.1). The engineered PikC fusion protein 
PikCD50ND176QE246A-RhFRED, which was designed by molecular dynamics-guided analysis (19), 
was used in our studies. The active site residues that were predicted to lead to unproductive 
substrate binding orientations were mutated in order to promote formation of the closed, active 
form of the enzyme. A collection of 13 triazole anchors was then assembled from seven azido 
acids and two amines. Triazoles examined include those derived from azido alkynes possessing 
and lacking chirality, ortho, meta, and para-spaced benzene spacers, and both 1,4- and 1,5-triazole 
regioisomers. Following installation of the triazole anchor to substrate 2, analytical scale 
biocatalytic oxidations on derivatives of 4 were performed, and promising anchors were selected 
from LCMS analysis based on percent conversion and selectivity for a major product. 
Representative cases were then conducted on a 30-60 mg preparative scale, products were isolated 
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by preparative HPLC, and the structure and stereochemistry of major products were elucidated by 
NMR. Isolated monohydroxylated products were then used as internal standards in the analysis of 
additional analytical scale experiments in order to identify anchors that enable synthesis of a 
different hydroxylated product.  
Using this approach, three different monohydroxylated products (5, 6, and 7) were obtained 
from substrate 4. Notably, triazoles possessing para- or meta-substituted benzene spacers a or b 
enable oxidation of allylic protons proximal to the point of anchor connection to provide product 
5. Alternatively, selection of anchors that possess a shorter linker motif enables oxidation of the 
distal region of the substrate. For example, using alanine-derived anchor c leads to the production 
of product 6c with oxidation - to the carbonyl. In contrast, anchor d with an ortho-substituted 
benzene spacer leads to product 7d with oxidation - to the carbonyl. No evidence for epoxidation 
or amine oxidation was observed in PikC-catalyzed oxidations, demonstrating desirable 
chemoselectivity features of C-H oxidation. Epoxide 8 is cleanly obtained (when R = Ac) in 
reactions with either m-CPBA as the electrophilic oxidant, or by using the White C-H oxidation 
catalyst (17), demonstrating orthogonal chemoselectivity of the PikC oxidation method. By 
installing anchor a, biocatalytic oxidation of 8a then cleanly affords epoxy alcohol 9a. The site-
selective oxidation to provide 5, 6, 7 or 9 demonstrates that this method is useful for oxidizing C-
H bonds that are either proximal or distal to the directing group. The versatile directing capability 
of the triazole linkers paired with PikC catalysis thus does not directly correlate with C-H bond 
strength, acidity, inductive influences, steric accessibility, or immediate proximity to the directing 
group. Instead, the enzyme active site conformation matched with the structure, stereochemistry, 
and conformation of both the triazole anchor and the substrate overrides these influences.  
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To probe the interrelationship of the stereochemical features of the active site residues, 
triazole anchor, and macrocyclic substrate, the enantiomeric form of the macrocycle (substrate 10) 
was examined with the same biocatalyst and triazole anchors a-d. By using the meta- and para-
substituted anchors a and b that enabled oxidation of the proximal allylic methylene in substrate 
4, these same anchors instead led to oxidation of distal protons - to the carbonyl to provide 
products 12a and 12b. Use of an alanine-derived anchor c or the ortho-substituted anchor d 
afforded 13c and 13d as the major product via oxidation - to the carbonyl. These results 
demonstrate that optimal anchor structure will vary from substrate to substrate, even within an 
enantiomeric series, thus adding appeal to the simple and potentially high throughput access to 
linkers in the approach described. 
In taking advantage of the regiodiverent access to macrocycles described, the 12-
membered structure derived from endocyclization was also examined in biocatalytic oxidations. 
In this case, two different oxidized products were obtained from substrate 14. The alanine anchor 
e provided access to allylic oxidation product 15e, and a diethylamine anchor was employed in 
this case to minimize N-demethylation, which was observed as a minor byproduct in some 
instances. Alternatively, using the ortho-linked benzene spacer d, major product 16d was obtained 
via oxidation - to the carbonyl. These results collectively illustrate that a variety of 
monohydroxylated compounds of macrocycles varying in ring size may be efficiently obtained 
starting from a single, easily accessible ynal substrate. 
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Table 3.2.1. Scope of biocatalytic macrocycle oxidation. R groups are depicted by the letters a-e 
shown at bottom. Major product is depicted in the table. Percent yield refers to conversion to 
monohydroxylated products, and ratios of monohydroxylated products are given in parentheses.  
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As described above, the structure, stereochemistry, and conformation of the substrate, 
linker, and enzyme active site all play important roles in determining site selectivity of the C-H 
oxidations. In order to understand these influences and to add a predictive component to the 
strategy, a combined density functional theory (DFT) and molecular dynamics (MD) 
computational study was undertaken. DFT was used to compute the intrinsic reaction barriers to 
C-H abstraction at C3 allylic and C10 alpha positions of 4. The R group shown in 4 was truncated 
to a methyl, and conformations of the macrocycle were explored with MMFF in Spartan (30). 
These conformers were then optimized, and single point energy calculations were performed with 
DFT in Gaussian09. The lowest energy conformer was identified along with a second low energy 
conformer only 0.9 kcal/mol higher in energy. All other conformers were >2 kcal/mol higher in 
energy than conformer 1.  The barriers to C-H abstraction at C3 and C10 were computed for these 
two low energy conformers and are shown in Figure 3.2.2A. The barriers to abstraction of the 
hydrogens shown in purple and green are the lowest for each site of both conformers, and 
correspond to the hydrogens that are abstracted to form 5 and 6. Figures 3.2.2B and 3.2.2C show 
the transition structures for abstraction of the C3 purple (equatorial) and C3 yellow (axial) 
hydrogens, respectively, from conformer 1. It is clear from close inspection of the transition 
structures that the abstraction of the equatorial hydrogen (purple) benefits from developing 
conjugation with the neighboring exocyclic alkene. The axial hydrogen (yellow) is perpendicular 
to the π-system and cannot benefit from the allylic stabilization. A similar conjugation effect is 
seen with the C-H abstractions at C10. The green hydrogen is in conjugation with the carbonyl 
group (Figure 3.2.2D), but the ring must distort for the blue hydrogen to benefit from the same 
stabilization. The substrate prefers a dihedral of 16.1⁰ between the exocyclic alkene and the 
 71 
 
carbonyl. In Figure 3.2.2E, this dihedral expanded to 55.6⁰ in the transition structure for the 
abstraction of the blue hydrogen.  
Conformer 1 was used for molecular dynamics simulations. Linker a and linker c were 
each attached to the macrocycle and docked into the active site of the PikC D50N/D176Q/E246A, and 
500ns trajectories were run on each of these complexes using Amber. Over the course of the 
simulations, both conformer 1 and conformer 2 are observed. As shown in the snapshot of Figures 
3.2.3A and 3.2.3B, linker a places C3 closest to the active iron-oxo. C2 is also placed close to the 
iron-oxo (3.7 Å averaged over the 500ns simulation), but the computed barriers to abstraction at 
C2 are +5 kcal/mol higher in energy than at C3 (Figure 3.2.4). Alternatively, linker c places C10 
closest to the iron-oxo species. Figures 3.2.3C and 3.2.3E show the average distance of each 
hydrogen to the iron-oxo oxygen over the course of the 500ns simulations. Figures 3.2.3D and 
3.2.3F are plots of the Hsubstrate-Oiron distances vs. C-H-O angles over the course of the trajectories 
with linkers a and c respectively. Figures 3.2.3C and 3.2.3D reveal that the purple hydrogen is 
closest to the DFT-computed transition state geometry. Collectively these data show that the 
purple, equatorial hydrogen of C3 is the most accessible to the iron-oxo in the enzyme and 
intrinsically more reactive. Figures 3.3.3E and 3.2.3F show that the blue hydrogen is closest to the 
DFT-computed transition state geometry, but abstraction of this hydrogen is disfavored by up to 
1.1 kcal/mol. While linker c places C10 closest to the iron-oxo, the intrinsic reactivity of the 
equatorial hydrogen (green) overrides the proximity of the axial hydrogen (blue). MD simulations 
of 4d and 14e were able to help understand the preference of the corresponding major products, 
7d and 15e respectively (Figures D.S1-D.S3). The combined DFT and MD study provides an 
explanation for the observed regiochemistry and stereoselectivity of these PikC-catalyzed 
hydroxylations.  
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Figure 3.2.2. (A) Lowest energy conformers of a model of structure 4, with DFT barriers 
(kcal/mol) to C-H abstraction at C3 and C10; (B) Transition structure of C3 (purple) hydrogen 
abstraction; (C) Transition structure of C3 (yellow) hydrogen; (D) Transition structure of C10 
(green) hydrogen abstraction; (E) Transition structure of C10 (blue) hydrogen abstraction. 
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Figure 3.2.3. (A) Snapshot of MD trajectory of 4 with linker a overlaid with a snapshot of 4 with 
linker c. (B) Closeup of Figure 3.2.3A snapshot with average C-OFe distances shown. (C) Snapshot 
of 4 with linker a with average H-O distances shown. (D) Plot of hydrogen (of substrate C3) to 
oxygen (of iron-oxo) distances vs C-H-O angles throughout the MD trajectory, with TS geometry 
shown in red; (E) Snapshot of 4 with linker c with average H-O distances shown; (F) Plot of 
hydrogen (of substrate C10) to oxygen (of iron-oxo) distances and C-H-O angles throughout the 
MD trajectory, with TS geometry shown in red. 
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Figure 3.2.4. DFT computed barriers to C-H abstraction from conformer 1 of model 4. 
In summary, this study describes a versatile strategy for the rapid generation of a collection 
of macrocyclic compounds that differ in ring size and oxidation pattern. Starting from a single 
linear substrate, catalyst control in a regiodivergent macrocyclization is paired with site-selective 
C-H oxidations enabled by the synergy of a computationally-designed engineered cytochrome 
P450 catalyst and a tailored amine-containing directing group. Computational analysis uncovers a 
complex synergy of macrocycle conformation, inherent reactivity of various C-H bonds, linker 
structure, and substrate-active site interactions in controlling site selectivity of C-H oxidation. This 
work provides a general strategy and new opportunities for diversification through late-stage 
functionalization of a broad array of substrate classes. 
Supporting Information 
Details on how computations were performed and additional computational figures are given in 
Appendix D. 
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Chapter 4.1 
Mechanism of the P450-Catalyzed Oxidative Cyclization in the Biosynthesis of Griseofulvin 
Jessica M. Grandner, Ralph A. Cacho, Yi Tang, K. N. Houk 
Introduction 
Scheme 4.1.1. Griseofulvin (3) and biosynthetic scheme highlighting the role of P450 GsfF. 
 
Griseofulvin (3), originally of interest for its antifungal activity, has more recently been 
reported to have both anticancer1 and antiviral2 activity in mammals.3 The important biological 
applications and intriguing spirocyclic core of 3 make it a compound of interest to biochemists and 
synthetic chemists alike. The Tang group reported the genes in Penicillium aethiopicum 
responsible for the biosynthesis of 3 in 2010,4 and subsequently determined the full biosynthetic 
pathway in 2013.5 One important discovery made during the elucidation of this pathway was that 
a P450 enzyme (herein referred to as GsfF, as it is encoded in the gsf gene cluster) is responsible 
for the important oxidative cyclization of griseophenone B (1) to desmethyl-dehydro griseofulvin 
A (2), shown in Scheme 4.1.1. Intermediate 2 only requires methylation and stereoselective 
reduction by two subsequent enzymes to afford the natural product 3.5 The mechanism by which 
this P450 produces 2 has been explored with a combination of density functional theory (DFT), 
homology modeling, docking, and experiment to determine how this stereoselective oxidative 
cyclization occurs.   
Computational Methods  
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DFT calculations were performed using Gaussian 09.6 Geometry optimizations and 
frequency calculations were performed using unrestricted B3LYP (UB3LYP)7 with the LANL2DZ 
basis set for Fe and 6-31G(d) on all other atoms. Transition states had one negative force constant 
corresponding to the desired transformation. Enthalpies and entropies were calculated for 1 atm 
and 298.15 K. A correction to the harmonic oscillator approximation, as discussed by Truhlar and 
co-workers, was also applied to the entropy calculations by raising all frequencies below 100 cm-
1 to 100 cm-1.8 Single point energy calculations were performed using the functional (U)B3LYP-
D3(BJ)9 with the LANL2DZ basis set on iron and 6-311+G(d,p) on all other atoms. Where 
relevant, single points with solvent corrections were performed using the PCM continuum model 
with both water and chlorobenzene.10 Transition structures were connected to intermediates via 
IRC calculations. 
Homology models for GsfF were generated using the Robetta online server 
(http://robetta.bakerlab.org/).11 The Rosetta fragment insertion method was used to provide both 
ab initio and comparative models of the target protein. The resulting homology model, following 
truncation of the putative membrane-anchoring N-terminal helix (first 53 residues of GsfF), was 
subjected to full-atom structural refinement using the Rosetta “relax” application with the iron 
atom of the heme ligand constrained to within 2.3 Å of the catalytic Cys450.12 A total of 300 
refined models were generated from the Rosetta “relax” protocol with the 20 highest scoring 
models within a root mean square deviation (RMSD) of 0.356 Å from the top scoring model. 
Autodock Vina13 was used to perform docking on the highest-ranked, refined homology model 
obtained above, without membrane-anchoring N-terminal helix. Residues TYR49, TRP52, 
LEU159, ALA165, THR253, ALA254, ASP257, ALA258, TYR434, PHE435 were allowed to be 
flexible, along with the substrate, during the docking procedure. The box within which the ligand 
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was allowed to be position contained the flexible residues and was positioned above the heme iron. 
Nine poses were obtained as a result of the docking, and all are given in the Supporting 
Information.   
Results and Discussion 
Three possible mechanisms, Scheme 4.1.2, were explored computationally to determine 
how GsfF catalyzes the transformation of griseophenone B (1) to desmethyl-dehydro griseofulvin 
A (2). Pathways A and C were originally proposed in Cacho et al.’s paper in 2013.5 In pathway A, 
initial O-H abstraction from ring A is followed by a second phenolic abstraction from ring B and 
radical coupling to yield 2. In pathway C, the enzyme could catalyze the epoxidation of ring A to 
form an arene oxide intermediate. Nucleophilic opening of the epoxide by the neighboring phenol 
then yields a hemiacetal, which then rearomatizes through the loss of water. Pathway B was newly 
proposed in this manuscript as a way the enzyme could perform O-H abstraction but avoid 
diradical formation. Initial phenolic O-H abstraction from ring B could be followed directly by 
ring closure. Subsequent phenolic O-H abstraction from ring A of the preformed spirocycle would 
also lead to 2. 
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Scheme 4.1.2. Three possible mechanisms for the P450-catalyzed transformation of 1 to 2.  
 
Initially, the epoxidation of ring A of 1 was explored, following the studies of arene 
oxidations that have been examined computationally by Shaik and others.14,15,16,17,18 Many arene 
oxidation reactions, including epoxidation, are said to go through a common intermediate 
involving a tetrahedral, iron-oxo bound arene.16 Two orientations for the formation of this 
tetrahedral intermediate have been determined, a “face-on”17 approach and a “side-on” 16,18 
approach.19 For productive arene oxide formation, the iron-oxo attack must occur at either carbon 
8, 9, or 13 ring A, which all have non-hydrogen substituents. For this reason, a “face-on” approach 
was studied. 
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Figure 4.1.1. Lowest energy transition states20 for the three possible pathways outlined in Scheme 
4.1.2. Forming bonds are dashed and highlighted in green.  
The lowest energy transition structure for the formation of the tetrahedral intermediate is 
shown in Figure 4.1.1, 4-TS. This transition state was then compared to the two possible O-H 
abstraction transition states, 5a-TS and 5b-TS, to determine the likelihood of epoxidation. As 
shown in Figure 4.1.1, O-H abstraction from either ring is substantially favored over tetrahedral 
intermediate formation. Transition state 4-TS can also have mixed radical/cationic character, 
which varies with substituents. 15-19 Using NBO charges,21 there is a change in the total charge of 
ring A from isolated reactant to the transition state 4-TS equal to +0.44. Therefore, single points 
calculations were repeated using the PCM model for both water and chlorobenzene.10 4-TS is 
stabilized by both solvents, 1.7 kcal/mol in water and 0.9 kcal/mol in chlorobenzene. This small 
stabilization from implicit solvent does not compensate for the inherent preference for O-H 
abstraction. Due to the large difference in energy between 4-TS the O-H abstraction mechanisms, 
an epoxidation mechanism as outlined in Scheme 4.1.2 is unlikely. 
The oxa-spiro ring of griseofulvin is also formed nonenzymatically by radical oxidation of 
similar substrates catalyzed by iron. In the first synthesis of griseofulvin, Day and co-workers 
5a-TS (doublet) 
ΔΔG‡ = +0.5 
5b-TS (quartet) 
ΔΔG‡ = 0.0 
4-TS (doublet) 
ΔΔG‡ = +18.7 
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utilized aqueous potassium hexacyanoferrate(III)22 to cyclize the 5-methoxy analogue of 1, or 
griseophenone A, to the respective analogue of 2 (5-methoxy-2).23 Kuo et al. used a similar 
transformation in their total synthesis of 3.24 The preference for O-H abstraction over epoxidation 
is supported by these total syntheses.23,24 Schyman, Shaik, and co-workers discuss the discovery 
that in the biosynthesis of dopamine by Cytochrome P450 enzyme CYP2D6, the formation of the 
covalent iron-oxo complex is much higher in energy than a mechanism involving phenolic O-H 
abstraction and subsequent rebound.10,25 Several others have proposed similar dual abstraction 
mechanisms. Gesell et al. propose a phenolic coupling by the CYP719B1 to form salutaridine.26 
Holding and Spencer also propose similar phenolic coupling mechanisms in the biosynthesis of 
chloroeremomycin.27 Yong, Wang, and co-workers computationally demonstrated that a “reversed 
dual hydrogen abstraction” (R-DHA) mechanism, which involves a rate limiting O-H abstraction 
from the hydroxyl group of ethanol and subsequent C-H abstraction from the neighboring carbon, 
can be the predominant mode of oxidation depending on the environment.28 The overall ΔG‡ of 
abstraction ring A is 7.1 kcal/mol and 2.9 kcal/mol for ring B, with respect to each corresponding 
prereaction complex. These barriers are fairly low but are comparable to previous calculated 
barriers from the literature referenced above. For the oxidation of tyramine, the B3LYP portion of 
the QM/MM calculations gives a ΔE‡ for O-H abstraction of 10.4 kcal/mol with respect to the pre-
reaction complex.10 When the D3 dispersion correction is applied, the ΔE‡ value decreases to 9.7 
kcal/mol. From the respective complex, the ΔE‡ of 5b-TS is 6.1 kcal/mol when the D3(BJ) 
dispersion correction is included and 8.3 kcal/mol without dispersion. This barrier is very 
comparable to that of the tyramine O-H abstraction. The O-H abstraction of the R-DHA 
mechanism has a computed ΔE‡ of 16.3 kcal/mol, with no dispersion corrections included.28 The 
substituents of ring B in 1 are able to stabilize the developing radical character in the transition 
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state via resonance and thereby slightly lower the barrier to abstraction, compared to that of ethanol 
or even tyramine. Initial O-H abstraction from ring B is favored by +0.5 kcal/mol over abstraction 
from ring A. The inherent preference for O-H abstraction from ring B is due to a greater number 
of favorable dispersion interactions. When the D3(BJ) correction is not applied, initial O-H 
abstraction from ring A is favored by 3 kcal/mol. 
 
Figure 4.1.2. Iron-oxo catalyzed formation of 2 with initial O-H abstraction from ring B (energies 
given in kcal/mol). 
Figure 4.1.2 shows the energy profile following O-H abstraction from ring B.29 Initial 
hydrogen abstraction from ring B (5b-TS) has a low barrier of 2.9 kcal/mol. After formation of 
6b, the newly formed oxy-radical could directly attack ring A via 7b-TS with a barrier of 15 
kcal/mol, shown in green. This transition state leads directly to intermediate complex 8b, shown 
in Figure 4.1.3. A scan of the OFe-HringA distance reveals no barrier to the second O-H abstraction.30 
Alternatively, 6b could undergo a mechanism similar to pathway A of Scheme 4.1.2.  Reorientation 
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of the substrate to 9b involves a shift in substrate binding to the iron-hydroxo, or cpdII. Product 
complex 6b involves a OringB-HcpdII hydrogen bond while pre-reaction complex 9b involves an 
HringA-OcpdII hydrogen bond. This reorientation is likely not feasible without deleterious side 
reactions with either highly reactive intermediate. Additionally, while the barrier could from 6b to 
9b could not be calculated for this QM model, it is highly likely that the barrier to reorientation is 
higher in energy than the barrier to direct attack via 7b-TS.  If the reorientation could occur, O-H 
abstraction from ring A via 10b-TS is essentially barrierless (ΔE‡ = 2.3 kcal/mol from 9b in the 
quartet state), shown in purple. Diradical intermediate 11b has a low coupling barrier 12b-TS of 
3.4 kcal/mol.  This reaction is very favorable with at ΔGrxn of -43 kcal/mol. The exergonic nature 
of this reaction is similar to other reported oxidations involving O-H abstractions. For the R-DHA 
mechanism, the ΔErxn is downhill by -60 kcal/mol.28  
 
Figure 4.1.3. Transition structures for 7b-TS (left), 8b, and 10b-TS (right). Forming bonds are 
dashed and highlighted in green. 
The lowest energy conformation of the substrate, as shown in the transition states of Figure 
4.1.1, is preorganized to undergo ring coupling. Interactions of side chain in the binding site are 
not required to orient the substrate in a way that favors reaction. The homology model shown in 
10b-TS 8b 7b-TS 
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Figure 4.1.4 reveals a highly hydrophobic active site above the iron-heme. The hydrophobicity of 
the active site suggests that there will be a low concentration of water within the binding pocket 
and little involvement of the side chains in stabilization of radical transition states. The neutral 
substrate studied here does not require stabilization within the active site. The hydrophobicity of 
the active site, preorganization of the substrate, and neutral character of the substrates/transition 
states all validate our use of the QM model in the gas phase. Figure 4.1.5a shows a chemically 
relevant binding mode for abstraction from ring A, ranked first among all binding poses, and Figure 
4.1.5b is a chemically relevant binding mode for abstraction from ring B. The establishment of 
these two binding poses indicates the ability of the active site to accommodate the necessary 
substrate in orientations for both O-H abstractions. While these binding poses do not exactly 
resemble the corresponding prereaction complexes calculated by QM, the docked poses show that 
the substrate does fit in the homology model in modes primed for O-H abstraction.   
 
Figure 4.1.4. Apo homology model of GsfF. Active site residues are shown as lines, while iron-
heme and axial cysteine are shown as sticks. 
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Figure 4.1.5. Docked poses for (A) abstraction from ring A and (B) abstraction from ring B. 
Substrate is shown in yellow, flexible residues are shown in silver, and other active site residues 
are shown in blue (including iron-heme).  
Shaik and co-workers found that proton-coupled electron transfer between active site 
residues/water molecules was essential for the C2-C2 bond coupling of two linked indoles. While 
the C2-H bonds of indole have a calculated bond dissociation enthalpy (BDE) of 117.5 kcal/mol,31 
the calculated phenolic O-H BDE is 82.9 kcal/mol.32 For comparison, the BDE of the benzylic C-
H in toluene is calculated to be 89.8 kcal/mol.33 The bond enthalpy indicates that C2-H abstraction 
from indole is inaccessible and an alternative path to C2-C2 coupling is operative. On the other 
hand, abstraction of the phenolic O-H atoms from 1 is feasible and can proceed though the 
calculated pathway.  
In either pathway shown in Figure 4.1.2, the C-O coupling is the highest energy barrier. 
For the case of cholesterol 7α-hydroxylation, the first reduction of Fe3+ to Fe2+ during catalyst 
regeneration was postulated to be rate-limiting. 34,35 For many other P450 enzymes, the second 
reduction of the dioxygen complex is rate-limiting.14,36,37 GsfF is a member of the eukaryotic 
membrane-bound cytochrome P450 family, which uses a separate enzyme, the cytochrome P450 
reductase, to donate electrons from NADPH to the heme cofactor during the catalytic cycle.38 It is 
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likely that, as with the other P450 enzymes, one of the reduction steps is rate-limiting and, 
therefore, observation of a 13C or 18O kinetic isotope effect is unlikely.  
In the discussion above, we have proposed a likely mechanism for the oxidation of 
griseophenone B based on DFT model calculations. We conclude that a hydrogen-atom 
abstraction-based mechanism occurs rather than epoxidation, due to the large energy difference in 
the computed transition states. We propose that O-H abstraction at ring B is followed directly by 
spirocyclic ring formation then subsequent abstraction from ring A to yield 2. We do acknowledge 
that the intricate mechanistic detail following O-H abstraction is ultimately determined by the 
enzymatic environment. The overall barriers for O-H abstraction from ring A and ring B are very 
close in free energy and, therefore, binding of the substrate will determine which hydrogen is 
abstracted first. If abstraction from ring A occurs first, the resulting radical cannot undergo direct 
spirocyclic ring formation, as shown in Figure 4.1.2, and reorientation of the active radical would 
be required. As with the reorientation of 6b to 9b, we believe that the reorientation of the radical 
resulting from abstraction of ring A is unlikely to occur without deleterious side reactions. 
Quantum mechanics/molecular mechanics (QM/MM) calculations can address these minute 
details, but are best obtained based on a crystallographic structure, which is not available at this 
time. 
We have explored the abstraction of the phenolic hydrogen of ring B which leads to the 
observed product, but there is an alternative phenolic hydrogen present at C5. There were no shunt 
products observed that would have been derived from abstraction of this hydrogen.5 We postulate 
that this is due to the strong hydrogen bond that forms between the C5-hydroxyl and the bridging 
carbonyl. This hydrogen bond is present in the lowest energy conformation of the substrate, as 
seen in the transition state structures of Figure 4.1.1. The presence of this hydrogen bond helps 
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preorganize the substrate for attack of ring B onto ring A. Methylation of the C5-hydroxyl group 
occurs after the cyclization step in the biosynthesis of griseofulvin,5 and we postulate that 
preorganization of the substrate plays a role in the feasibility of the cyclization. It has also been 
shown that griseophenone A, is not cyclized to the natural product.39 Figure 4.1.6 shows that the 
lowest energy conformation of griseophenone A, 13a, is 8.0 kcal/mol lower in energy than the 
“active” conformation, 13b, which is similar to 1. 
 
Figure 4.1.6. Conformations and relative free energies of griseophenone A.   
Conclusion 
A computational investigation of the oxidation of griseophenone B (1) to desmethyl-
dehydro griseofulvin A (2) by a P450 enzyme (GsfF) has been performed. We have determined 
that the phenolic coupling occurs through initial phenolic O-H abstraction rather than arene 
oxidation, as shown in Figure 4.1.1. After O-H abstraction, the oxygen radical of ring B can 
directly attack the neighboring arene to form the spirocycle.  This finding is supported docking 
structures and recent computational investigations by Shaik and co-workers.10 This type of O-H 
abstraction is quite facile and is likely a common mode of phenolic oxidation because it avoids the 
high barriers involved in arene oxide formation.  
 
C5 
C5 
13a 
Preferred Conformation of Griseophenone A  
ΔΔG = 0.0 kcal/mol 
13b 
Active Conformation (similar to 1) 
ΔΔG = +8.0 kcal/mol 
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SUPPORTING INFORMATION 
Experimental procedures and details, computational details, and additional figures are given in 
Appendix E.  
Author Contribution and Notes 
QM calculations were performed by Grandner. Homology modeling and experimental work was 
performed by Cacho. Autodock Vina docking was performed by Grandner with the assistance of 
Blanton Martin. Images of homology modeling and docked poses were made in PyMol.40 Images 
of transition states were made using CYLview.41  
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Chapter 4.2 
Unusual Oxidative Cascade Reactions by Cytochrome P450s in the Biosynthesis of 
Fumagillin 
Jessica M. Grandner, Thomas Aunins, Robert D. Giacometti, Yi Tang, K. N. Houk 
Introduction 
Fumagillin (1) is a fungal-derived secondary metabolite.1 The Tang group identified the 
fma gene cluster and the P450 encoded within the cluster that is responsible for several oxidative 
steps in the biosynthesis of fumagillin.2 Af510 or Fma-P450 performs three sequential oxidative 
steps in the biosynthetic pathway.3 The mechanisms of the first C-H hydroxylation (2 to 3) and 
last olefin epoxidation (4 to 5) in this sequence have been thoroughly investigated.4 The second 
step of the P450 sequence is a unique oxidative C-C cleavage (3 to 4) responsible for revealing the 
core of the metabolite. While the role of this enzyme in the synthesis of the biologically active 
compound has been elucidated, the mechanism of the oxidative ring-opening has only been 
postulated.3,5 Understanding the mechanism is not only critical to determining synthetic 
approaches to similarly functionalized cores, but also to understanding possible modes of 
metabolism by human P450s. 
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Figure 4.2.1. Fumagillin (1) and the role of Fma-P450 in the biosynthesis. 
A proposed mechanism for the C-C cleavage is shown in Figure 4.2.2.3 An initial C-H 
abstraction would lead to radical 6, which could then be further oxidized to cation 7. Trapping of 
the cation by the iron-peroxo intermediate, naturally present in the P450 catalytic cycle, would 
lead to 8 which could convert to 4 as shown. A modified version of this mechanistic pathway has 
been proposed and discussed by Ortiz de Montellano.6  
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Figure 4.2.2.  Proposed mechanism (Path A) of formation of 4 from 3.3 Plain numbers (#) represent 
the native compounds (R = prenyl group) whereas numbers with an ‘x’ (#x) indicate truncated 
computational model compounds (R= ethyl). 
Alcohols can be converted into higher order oxidized products by P450s.7 Computational 
studies into the mechanisms of these oxidations by Grandner et al.8 and Shaik et al.9,10 have shown 
that O-H abstractions are facile for certain substrates and can compete with C-H abstraction 
barriers.  Two alternative mechanisms, (B and C; Figure 4.2.3) begin with an O-H abstraction from 
the bridgehead hydroxyl of 3.5 The oxygen centered radical 9 could cleave the neighboring C-C 
bridge to form a carbonyl and 3⁰ radical 10. The two alternative mechanisms diverge from 
intermediate 10. In path B, cpdII abstracts a hydrogen next to the radical to form alkene 11. 
Subsequent alkene epoxidation would lead to 4. In C-H oxidation mechanisms, the hydroxyl of 
cpdII rebounds with little or no barrier onto the developing radical.4a A similar rebound may occur 
onto the 3⁰ radical of 10, although it would be remote from the site of the initial hydrogen atom 
abstraction. In path C, a “remote-rebound” onto 10 could occur leading to 12. Sequential C-H and 
O-H abstractions, for a net loss of H2, could then lead to 4. We now report computational studies 
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that show which of these mechanisms for conversion of 3 to 4 is most likely. There have been 
similar experimental studies of such radical-based ring opening reactions by Ortiz de Montellano 
and coworkers. They used α- and β-thujone as a radical clock to distinguish between radical and 
cationic mechanisms11 and explored the mechanisms of oxidation by P450cam and P450BM3.
12 Our 
computational studies will elucidate how P450s can perform complex oxidative ring-opening 
reactions. 
 
Figure 4.2.3. Proposed O-H abstraction mechanisms for oxidation of 3 to 4. Plain numbers (#) 
represent the native compounds (R = prenyl group) whereas numbers with an ‘x’ (3x) indicate 
truncated computational model compounds (R= ethyl). 
 
 
 
 
 
98 
 
Computational Methods 
 
Figure 4.2.4. Computational models used for cpdI and cpdII 
The prenyl group of all relevant compounds was truncated to an ethyl group, as noted in 
Figures 4.2.2 and 4.2.3. Computational models for cpdI and cpdII are shown in Figure 4.2.4.  
Conformational searches of substrate and organic intermediates were performed using the MMFF 
force field in Spartan.13 Conformational searches were not performed on the transition structures 
or iron-bound intermediates unless otherwise noted. Iron-containing intermediates and transition 
states were found from IRC calculations, scans, or using the lowest energy conformers of the 
respective organic compounds. All density functional calculations were performed using 
Gaussian09.14 Geometry optimizations and frequency calculations were performed at the B3LYP15 
level with LANL2DZ for Fe and 6-31G(d) for all other atoms. Frequency calculations were used 
to identify local minima (0 negative frequencies) and transition structures (1 negative frequency). 
Enthalpies and Gibbs free energies were also computed from frequency calculations at a standard 
state of 1 atm and 298.15 K.  A correction was applied to the Gibbs free energy by adjusting all 
frequencies below 100 cm-1 to 100 cm-1.16 Single point energy calculations were performed at the 
B3LYP-D3(BJ)17 level with LANL2DZ for Fe and 6-311+G(d,p) for all other atoms. All energies 
reported within are Gibbs free energies (kcal/mol) unless otherwise noted.  
Results and Discussion 
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We first explored the feasibility of the formation and oxidation of radical 6. An IRC of the 
transition state for C-H abstraction (13x) shows direct and barrierless formation of the 
hydroxylated product (15x) rather than a radical intermediate (14x) (Figure 4.2.5). Radical 6x does 
not form as a result of C-H abstraction in the gas phase and thereby does not lead to product by 
path A. If the enzyme could somehow stop this barrierless rebound, oxidation of 6 would require 
the reduction of cpdII. According to Rydberg et al., the reduction potential of cdpII is -2.11 V 
(+48.7 kcal/mol) in vacuum and -0.15 V (+3.5 kcal/mol) in water.18 Lastly, as shown in Figure 
4.2.6, attempts to optimize most conformers of cation 7x led to cleavage of one of the bridging 
bonds to form a more stable oxonium (16x) or allylic radical (17x).19 These data indicate that C-H 
abstraction leads to formation of the hydroxylated shunt product, but not to the observed product 
4.  
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Figure 4.2.5. Intrinsic reaction coordinate (IRC) diagram from the C-H abstraction transition state 
13x. 
 
Figure 4.2.6. Optimization of cation 7x does not maintain bridgehead bonds and instead leads to 
oxonium 16x or allylic cation 17x. 
The barrier to O-H abstraction from 3x is 14.0 kcal/mol. An IRC of the transition state 
reveals that O-H abstraction and C-C cleavage are concerted, albeit highly asynchronous. The free 
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energy diagrams for paths B and C are shown in Figures 4.2.7 and 4.2.8, respectively. A transition 
state for the remote rebound (18x to 10x) could not be obtained. In both pathways, O-H abstraction 
with simultaneous C-C cleavage is either rate-limiting or isoenergetic with subsequent steps. It is 
reasonable to expect that no intermediates along these pathways will be observed. Additionally, 
since the two pathways have identical rate-determining steps, either or both mechanisms could be 
operative within Fma-P450. 
 
Figure 4.2.7. Free energy diagram for Path B involving alkene formation. Numbers with ‘*’ are 
quartet single points on doublet geometries. Numbers with ‘#’ are doublet single points on quartet 
geometries.  
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Figure 4.2.8. Free energy diagram for Path C involving remote-rebound. Numbers with ‘*’ are 
quartet single points on doublet geometries.  
Previous experimental studies Rettie et al. 20 and Guan et al.21 have shown that P450s are 
capable of desaturation. Jennewein et al. found that a P450 catalyzes a remote-rebound onto an 
intermediate in the biosynthesis of Taxol.22 The radical clock studies by Ortiz de Montellano and 
coworkers have demonstrated both mechanisms can be performed on a single substrate.12  
The mechanism for epoxidation in Path C is an unusual proposal but energetically 
feasible.23 As shown in Figure 4.2.5, 13x avoids formation of the radical intermediate and leads 
directly to the hydroxylated product 15x. Alternatively, the IRC of 23x (Figure 4.2.9) reveals that 
rebound is not spontaneous and a radical intermediate is formed. The computed barrier to rebound 
from 24x, to form a syn-diol, is 1.2 kcal/mol higher in energy than 25x.24 There is a hydrogen bond 
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between the hydroxyl of 24x and compound II, shown in Figure 4.2.9, which likely raises the 
barrier to rebound and increases the probability of competitive O-H abstraction.   
 
Figure 4.2.9. IRC of 23x which shows that rebound is not spontaneous. 
Conclusion 
In conclusion, we have determined that the Fma-P450-catalyzed ring-opening oxidation in 
the biosynthesis of fumagillin begins with an atypical O-H abstraction. This O-H abstraction 
causes the spontaneous ring-opening of the bicycle to reveal the carbocyclic core of fumagillin. 
There are two mechanistic possibilities that could occur following the ring opening: 1) alkene 
formation and epoxidation or 2) remote-rebound and C-H/O-H abstraction. These findings 
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illustrate and support the novel mechanisms outside of C-H abstraction which can be performed 
by P450s.  
Supporting Information 
Additional figures are given in Appendix F.  
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MATERIALS AND ANALYTICAL TECHNIQUES 
All reactions were carried out in dry vials with PTFE-faced silicone septum under an argon 
(Ar) atmosphere or in a Vacuum Atmospheres Glovebox under a nitrogen atmosphere, as 
specified. All solvents and reagents were purchased from Sigma-Aldrich and used without 
further purification unless otherwise noted. Fresh ampules of CDCl3 (Sigma-Aldrich) were 
used in decomposition experiments of the ruthenium benzylidene catalysts. Complexes 1, 
2, 3, 6, and 7 were generously donated by Materia, Inc. Complexes 4 and 5 were prepared 
from 2 and 3, respectively, following a literature procedures.1,2 1H NMR spectra were 
recorded on one of the following instruments: Varian Mercury (300 MHz), Varian Inova 
(500 MHz), or Bruker Ascend with Prodigy broadband cryoprobe (400 MHz). Gel 
permeation chromatography (GPC) was conducted on two Agilent PLgel 10 μm MIXED-
BLS 300 mm × 7.5 mm columns with Agilent P260 series pump and autosampler with 
Wyatt Dawn Heleos-ΙΙ multi-angle static light scattering detector and Optilab T-rEX 
differential refractive index detector with THF as an eluent.  
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EXPERIMENTAL PROCEDURES 
General procedure for ATRA catalyzed by ruthenium benzylidene complexes.  
 
To a 8 mL vial with silicone septum cap equipped with a magnetic stir bar, complex 1 (62 
mg, 0.75×10-1 mmol), MMA (106.84 μL, 9.99×10-1 mmol), and 0.8 mL of CHCl3 (0.8 mL. 
9.98 mmol) were added. Anisole (10 µL, 9.20×10-2 mmol) was added as an internal 
standard. The solution was degassed with Ar (g) for 10 min, and the reaction was initialized 
by immersing the reaction vessel into an oil bath preheated to the specified temperature 
(65 °C or 40 °C). The reaction was kept under Ar (g), and aliquots were removed at 
predetermined time points and analyzed by 1H NMR to monitor reaction progress over time. 
After 2 h, the solution was precipitated into petroleum ether and filtered to remove 
precipitated catalyst. Solvent and unreacted MMA were dried using rotary evaporator. The 
yield of the product was calculated using 1H NMR integration at 6.01 ppm (-CCl2H from 
the product) and 1.84 ppm (–CH3 from the product and by-products). All of the ATRA 
reactions in this report were performed following this general procedure using the same 
molar ratio of [catalyst] : [MMA] : [CHCl3]. 
Computed ΔGrxn (kcal/mol) for ATRA reactions. 
Geometry optimizations and frequency calculations were performed at the (U)B3LYP 
level3-5 using LANL2DZ for Ru and 6-31G(d) on all other atoms. Thermal corrections were 
calculated from vibrational frequencies using a standard state of 1 atm and 298.15 K. All 
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frequencies below 100 cm-1 were raised to 100 cm-1 to correct entropies for the breakdown 
of the harmonic oscillator approximation as discussed by Truhlar.6 Subsequent single point 
energy calculation were performed at the (U)M06-L7 level using SDD for Ru and 6-
311+G(d,p) on all other atoms and including the SMD8 (chloroform) solvent model. All 
calculations were performed using Gaussian 09.9 
Decomposition study of ruthenium benzylidene complexes.  
 
Inside the glovebox, an NMR tube was charged with the ruthenium complex and CDCl3 in 
the same molar ratio as specified in the general ATRA procedure. The NMR tube was 
capped with a septum, removed from the glovebox, and heated at 65 °C. 1H NMR spectra 
were collected at predetermined time points, and the integral of the benzylidene resonance 
(16–20 ppm, 1H) was plotted as a function of time. 
110 
 
 
Figure A.S2. 1H NMR spectra of 1 at (a) 0 min and (b) 200 min after activation in CDCl3 
at 65 °C. 
111 
 
 
Figure A.S3. 13C NMR spectra of 1 at (a) 0 min and (b) 200 min after activation in CDCl3 
at 65 °C. 
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Figure A.S4. 31P NMR spectra of 1 at (a) 0 min, (b) 200 min after activation in CDCl3 at 
65 °C, and (c) bipy added after the activation. 
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Figure A.S5. 1H NMR spectra of 2 at (a) 0 min and (b) 270 min after activation in CDCl3 
at 65 °C. 
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Figure A.S6. 1H NMR spectra of 3 at (a) 0 min and (b) 60 min after activation in CDCl3 at 
65 °C. 
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Figure A.S7. 13C NMR spectra of 3 at (a) 0 min and (b) 60 min after activation in CDCl3 
at 65 °C. 
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Figure A.S8. 31P NMR spectra of 3 at (a) 0 min and (b) 60 min after activation in CDCl3 
at 65 °C, and (c) bipy added after the activation. 
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Figure A.S9. 1H NMR spectra of 4 at (a) 0 min and (b) 270 min after activation in CDCl3 
at 65 °C. 
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Figure A.S10. 1H NMR spectra of 5 at (a) 0 min and (b) 270 min after activation in CDCl3 
at 65 °C. 
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Figure A.S11. 1H NMR spectra of 6 at (a) 0 min and (b) 270 min after activation in CDCl3 
at 65 °C. 
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Figure A.S12. 1H NMR spectra of 7 at (a) 0 min and (b) 270 min after activation in CDCl3 
at 65 °C. 
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General procedure for ATRA catalyzed by activated ruthenium complexes.  
  
To a 8 mL vial with silicone septum cap equipped with a magnetic stir bar, complex 1 (62 
mg, 0.75×10-1 mmol), anisole (10 μL, 9.20×10-2 mmol), and CHCl3 (0.8 mL, 9.98 mmol) 
were added. The solution as degassed with Ar (g) for 10 min and then heated at 65 °C until 
complete disappearance of benzylidene 1H NMR resonance. The reaction vessel was 
allowed to cool to room temperature, and freshly degassed MMA (106.84 μL, 9.99×10-
1mmol) was added to the solution. The reaction was initialized by immersing the reaction 
vessel into an oil bath preheated to the specified temperature (65 °C or 40 °C) and was held 
under an Ar (g) atmosphere Aliquots were removed at predetermined time points and 
analyzed by 1H NMR to monitor reaction progress over time. All of the ATRA reactions 
in this report with pre-activated ruthenium benzylidene complexes were performed 
following this general procedure using identical concentrations.  
General procedure for ATRA catalyzed by ruthenium benzylidene complexes with 5 
equivalent of PCy3. 
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To a 8 mL vial with silicone septum cap equipped with a magnetic stir bar, complex 1 (62 
mg, 7.53×10-2 mmol), MMA (106.84 μL, 9.99×10-1mmol), anisole (10 μL, 9.20×10-2 
mmol) and CHCl3 (0.8 mL, 9.98 mmol) were added. PCy3 (105.64 mg, 3.77×10
-1 mmol) 
was then added, and the solution as degassed with Ar (g) for 10 min. The reaction was 
initialized by immersing the reaction vessel into an oil bath preheated to 65 °C and was 
held under an Ar (g) atmosphere. Aliquots were removed at predetermined time points and 
analyzed by 1H NMR to monitor reaction progress over time. Experiments with 2 and 3 
were performed following this general procedure using identical concentrations and 
reaction conditions.  
 
Figure A.S13. Rate profile of benzylidene 1H NMR resonance decay in CDCl3 with 5 
equivalent PCy3 relative to the catalysts. 
RCM catalyzed by 3 and benzylidene-decomposed (ATRA-activated) 3.  
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The reaction was performed following a literature procedure.10 Complex 3 (7.47 mg, 
8.01×10-3 mmol) was dissolved in degassed CDCl3 (0.75 mL). For reactions catalyzed by 
decomposed 3, the solution was then pre-treated at 65 °C until the indicated level of decay 
of benzylidene 1H NMR resonance was observed. After preparing the appropriate catalyst 
solution, the solution was cool to room temperature and diethyl diallylmalonate (19.3 μL, 
7.98×10-2 mmol) was added and a 1H NMR spectrum was collected after 1 h at 30 °C to 
calculate olefin conversion. 
Crystallization of ATRA-activated 1 with bipy.  
Complex 1 (62 mg, 0.75×10-1 mmol) was dissolved into 0.8 mL of CHCl3 (0.8 mL. 9.98 
mmol) and activated by heating at 65 °C until the complete decay of the benzylidene peak 
from 1H NMR was observed. The solvent was dried and powder was re-dissolved into 
minimal amount of DCM with addition of bipy (58.83 mg, 0.38 mmol). Pentane was added 
for the crystallization at room temperature.  
X-Ray structure determination. 
Low-temperature diffraction data (-and -scans) were collected on a Bruker AXS D8 
VENTURE KAPPA diffractometer coupled to a PHOTON 100 CMOS detector with Mo 
K radiation ( = 0.71073 Å) from an IμS micro-source for the structure of compound 
ATRA-activated 1 with bipy. The structure was solved by direct methods using SHELXS11 
and refined against F2 on all data by full-matrix least squares with SHELXL-201412 using 
established refinement techniques.13 All non-hydrogen atoms were refined anisotropically. 
All hydrogen atoms were included into the model at geometrically calculated positions and 
refined using a riding model. The isotropic displacement parameters of all hydrogen atoms 
were fixed to 1.2 times the U value of the atoms they are linked to (1.5 times for methyl 
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groups). All disordered atoms were refined with the help of similarity restraints on the 1,2- 
and 1,3-distances and displacement parameters as well as enhanced rigid bond restraints 
for anisotropic displacement parameters. The compound crystallizes in the triclinic space 
group P-1 with one molecule in the asymmetric unit along with 3.3 molecules of 
dichloromethane. Two of the cyclohexane moieties on the phosphine were disordered over 
two positions with appropriate restraints. The dichloromethane solvent is located in two 
cavities. One was modeled as a mixture of three solvent positions and the other over four 
positions. 
Table A.S1. Crystal data and structure analysis details for of ATRA-activated 3 with 
bipy (CCDC 1473173). 
Identification code  P15507 
Empirical formula  C41.26 H55.51 Cl8.51 N4 P Ru 
Formula weight  1041.00 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.1461(8) Å a= 95.620(3)°. 
 b = 13.3816(11) Å b= 94.475(3)°. 
 c = 18.3452(14) Å g = 104.537(3)°. 
Volume 2385.8(3) Å3 
Z 2 
Density (calculated) 1.449 Mg/m3 
Absorption coefficient 0.872 mm-1 
F(000) 1069 
Crystal size 0.100 x 0.100 x 0.100 mm3 
Theta range for data collection 2.244 to 30.603°. 
Index ranges -14<=h<=11, -19<=k<=18, -26<=l<=26 
Reflections collected 54887 
Independent reflections 14596 [R(int) = 0.0377] 
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Completeness to theta = 25.242° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7461 and 0.6938 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 14596 / 1155 / 719 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0597, wR2 = 0.1609 
R indices (all data) R1 = 0.0807, wR2 = 0.1749 
Extinction coefficient n/a 
Largest diff. peak and hole              1.869 and -0.896 e.Å-3 
ATRA catalyzed by Ru(III)Cl3 and PCy3 complex.  
First, 0.8 mL MeOH was added to Ru(III)Cl3 (15.54 mg, 0.75×10
-1 mmol) and PCy3 (42.02 
mg, 1.50×10-1 mmol) and refluxed overnight. The solution was then dried and filtered with 
benzene and filterate was dried again. To the dried powder MMA (106.84 μL, 9.99×10-1 
mmol) and 0.8 mL of CHCl3 (0.8 mL. 9.98 mmol) were added. Anisole (10 µL, 9.20×10
-2 
mmol) was added as an internal standard. The solution was degassed with Ar (g) for 10 
min, and the reaction was initialized by immersing the reaction vessel into an oil bath 
preheated to 65 °C.  
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Figure A.S14. Kinetic study of ATRA of MMA catalyzed by 3, activated 3, and Ru(III)Cl3 
refluxed with PCy3 (2 equiv).    
ATRP catalyzed by ruthenium benzylidene complexes.   
 
To a 8 mL vial with silicone septum cap equipped with a magnetic stir bar, ethyl α-
bromoisobutyrate (10 μL, 6.81×10-5 mmol), MMA (1.46 mL, 1.36×10-2 mmol), and 
complex 1 (56.07 mg, 6.81×10-5 mmol) were added and dissolved into toluene (681 μL). 
Anisole (10 μL) was added as an internal standard. The solution was degassed with Ar (g) 
for 10 min, and the reaction was initialized by immersing the reaction vessel into an oil 
bath preheated to 85 °C.  Aliquots were removed at predetermined time points and analyzed 
by 1H NMR and GPC to monitor, MMA conversion, Mn, and dispersity (Đ) over time. All 
of the ATRP reactions in this report were performed following this same general procedure 
under identical reaction conditions.  
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Initial Mechanistic Studies of ATRA/ATRP with W, X, Y, and Z  
 
Figure A.S15. Computed pathways for intra- (top) and intermolecular (bottom) inner-
sphere electron transfer with W (from reference 20 in Chapter 1.1). 
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Figure A.S16. Computed barriers to intra- (top) and intermolecular (bottom) inner-sphere 
electron transfer with second generation version of W (from reference 20 in Chapter 1.1).  
These initial mechanistic studies were performed to determine which mechanism 
was operative for ATRP with W in reference 20 in Chapter 1.1 and if a second generation 
version X would improve catalysis. These preliminary computations showed that it was 
unlikely an intact catalyst was performing ATRP catalysis. These led to the further 
experimental and computational exploration contained in Chapter 1.1. These preliminary 
computations were performed similarly to those discussed above and in the text except 
single points were performed with M0614/SDD/6-311+G(d,p) (SMD: Toluene) 
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Experimental Details 
General Information. 
Unless otherwise specified, all reactions were carried out under a nitrogen atmosphere in a 
Vacuum Atmospheres Glovebox in dry glassware. Solvents were purified by passage through 
solvent purification columns and sparged with argon. THF-d8 was dried over Na/benzophenone, 
vacuum transferred into a dried Schlenk flask, and subsequently degassed by methods of freeze-
pump-thaw. Phenyl vinyl ether was prepared by literature procedure.1 Phenyl vinyl ether and butyl 
vinyl ether (Sigma-Aldrich) were sparged with argon and filtered over neutral alumina 
(Brockmann I) prior to use. Catalysts 3 and 4 were provided by Materia, Inc.  
Standard NMR experiments were conducted using a Bruker 400 MHz instrument and a 
Varian Inova 400 MHz instrument unless otherwise specified. Chemical shifts are reported in ppm 
downfield using the residual solvent peak as a reference. NMR spectra were analyzed and 
processed using MestReNova version 8.1.2-11880. 
A JEOL MSRoute mass spectrometer was used to obtain high-resolution mass-
spectrometry data using FAB+ ionization. 
Synthesis of 2-isopropoxybenzaldehyde 
 
 To a Schlenk flask charged with a stir bar was added potassium carbonate (4.54 g, 32.8 
mmol). After evacuating and refilling the flask with argon three times, 15 mL dry DMF, 
salicaldehyde (1.00 mL, 9.38 mmol), and 2-iodopropane (1.12 mL,11.2 mmol) was added. After 
stirring at 45 °C overnight, the reaction was quenched with water. The aqueous phase was 
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extracted with ether (3×150 mL). The organic layer was then washed with water (3×100 mL) and 
dried over anhydrous MgSO4, filtered, and solvents were removed in vacuo (1.12 g, 72%). 
Spectroscopic data was in accordance with those provided previously in the literature.2 1H NMR 
(400 MHz, chloroform-d1) δ 10.51 (d, J = 0.8 Hz, 1H), 7.85 (dd, J = 7.9, 1.9 Hz, 1H), 7.54 (ddd, 
J = 8.4, 7.3, 1.9 Hz, 1H), 7.01 (dddd, J = 7.9, 3.9, 2.5, 0.9 Hz, 2H), 4.70 (heptd, J = 6.1, 0.6 Hz, 1H), 
1.42 (d, J = 6.1 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 190.38, 160.74, 135.90, 128.42, 
125.80, 120.51, 114.09, 71.20, 22.12. 
Synthesis of 2-isopropoxystyrene. 
 
To a Schlenk flask charged with a stir bar was added methyltriphenylphosphonium 
bromide (652.6 mg, 1.827 mmol) and potassium tert-butoxide (205.0 mg, 1.827 mmol). After 
evacuating and refilling the flask with argon three times, 25 mL of dry diethyl ether was added, 
and the reaction mixture was stirred for 1 hour at 0 °C. 2-isopropoxybenzaldehyde (100.0 mg, 
0.6096 mmol) was then added, and the reaction mixture was stirred for an additional hour at 0°C. 
Saturated aqueous NH4Cl solution was then added to the mixture, and the aqueous phase was 
extracted with Et2O (3×10 mL). The organic layer was dried over anhydrous MgSO4, filtered, and 
solvents were removed in vacuo. The crude product was purified by column chromatography on 
silica using pentane as the eluent, giving the pure product (79.0 mg, 80%) as a colorless oil.  
Spectroscopic data was in accordance those provided previously in the literature.3 1H NMR (400 
MHz, THF-d8) δ, 7.45 (dd, J = 7.7, 1.7 Hz, 1H), 7.14 (ddd, J = 8.7, 7.4, 1.7 Hz, 1H), 7.04 (dd, J = 
17.8, 11.2 Hz, 1H), 6.91 (dd, J = 8.3, 1.1 Hz, 1H), 6.83 (td, J = 7.4, 1.1 Hz, 1H), 5.69 (dd, J = 17.9, 
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1.7 Hz, 1H), 5.13 (dd, J = 11.2, 1.7 Hz, 1H), 4.57 (hept, J = 6.1 Hz, 1H), 1.30 (d, J = 6.0 Hz, 6H). 
13C NMR (101 MHz, THF) δ, 155.94, 132.82, 129.23, 128.32, 126.84, 120.93, 114.47, 113.23, 
70.90, 22.22. 
Synthesis of Ru-Hydride Species From Reaction of 3 with Phenyl Vinyl Ether (Reaction 1) 
 
To a 4 mL vial charged with a stir bar was added catalyst 3 (2.2 mg, 0.0035 mmol), 0.65 
mL THF-d8, and phenyl vinyl ether (1.1 μL, 0.010 mmol). After 5 hours, a ruthenium-hydride 
species could be seen by the appearance of a singlet in the 1H NMR (400 MHz) at -12.16 ppm. 
Synthesis of Ru-Hydride Species From Reaction of 4 with Phenyl Vinyl Ether (Reaction 2) 
 
To a 4 mL vial charged with a stir bar was added catalyst 4 (2.4 mg, 0.0035 mmol), 0.25 
mL of THF, and phenyl vinyl ether (9.2 μL, 0.0875 mmol). After 4 hours, a 100.0 μL aliquot of 
the reaction mixture was added to 0.6 mL THF-d8
 in a NMR tube. The formation of the ruthenium-
hydride species was seen by the appearance of a singlet in the 1H NMR (400 MHz) at -11.97 ppm.  
 
Synthesis of Ru-Hydride Species From Reaction of 3 with Butyl Vinyl Ether (Reaction 3) 
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To a J. Young tube was added catalyst 3 (60.0 mg, 0.0711 mmol), 0.65 mL of THF-d8, and 
butyl vinyl ether (9.21 μL, 0.0711 mmol). After taking a 1H NMR spectrum after 10 minutes to 
see the initial formation of the Fischer carbene, the reaction to form complex was completed 
overnight at room temperature. Analysis by 1H, 13C, 1H-1H COSY, 1H-13C HSQC, and 1H-13C 
HSQC NMR spectroscopy were conducted using a Bruker 400 MHz instrument. 13C-DEPT NMR 
studies were performed using a Varian Inova 400 MHz instrument. 1H NMR (400 MHz, THF-d8) 
δ, 6.81 (d, 2H), 5.11 (s, 1H), 3.94 (dt, J = 9.8, 6.2 Hz, 1H), 3.66 (m, 1H), 3.52 (t, 1H), 3.41 (td, J 
= 10.0, 4.2 Hz, 1H), 3.30-3.15 (m, 2H), 2.58 (dt, J = 11.9, 3.0 Hz, 1H), 2.32-2.17 (m, 6H, 
overlapping), 2.22 (s, 3H), 2.17 (s, 3H), 2.10 (s, 3H), 1.94-1.75 (m, 6H), 1.62-1.49 (m, 2H), 1.45-
1.35 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H), -12.63 (s, 1H). 13C NMR (101 MHz, THF) δ 218.56, 137.64, 
137.40, 136.89, 136.52, 129.57, 129.02, 93.09, 71.16, 65.38, 60.43, 51.93, 44.88, 41.52, 38.67, 
38.33, 38.29, 35.16, 33.14, 32.92, 31.61, 30.85, 21.01, 20.14, 18.13, 17.75, 14.20. HRMS (FAB+): 
Calculated – 570.1906, Found – 570.1896.  
Synthesis of Ru-Hydride Species From Reaction of 4 with Butyl Vinyl Ether (Reaction 4) 
 
To a J. Young tube was added catalyst 4 (5.3 mg, 0.0079 mmol), 0.65 mL of THF-d8, and 
phenyl vinyl ether (20.4 μL, 0.158 mmol). Decomposition to the ruthenium-hydride species was 
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completed overnight at room temperature as seen by the appearance of a singlet in the 1H NMR 
(400 MHz) at -12.50 ppm. 
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Figure B.S1. 1H NMR (CDCl3, 400 MHz) Spectrum of S1. 
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Figure B.S2. 13C NMR (CDCl3, 101 MHz) Spectrum of S1. 
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Figure B.S3. Stacked 1H NMR (THF-d8, 400 MHz) Spectrum of S2 and 
Reaction 3. 
140 
  
Figure B.S4. 1H NMR (THF-d8, 400 MHz) Spectrum of S2. 
141 
  
Figure B.S5. 1H NMR (THF-d8, 400 MHz) Spectrum of Reaction 3. 
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Figure B.S6. Stacked 13C NMR (THF-d8, 101 MHz) Spectrum of 2 and 
Reaction 3. 
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Figure B.S7. 13C NMR (THF-d8, 101 MHz) Spectrum of 2. 
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Figure B.S8. 13C NMR (THF-d8, 101 MHz) Spectrum of Reaction 3. 
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Figure B.S9. 1H-1H COSY NMR (THF-d8) Spectrum of Reaction 3. 
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Figure B.S10. 1H-13C HSQC NMR (THF-d8) Spectrum of Reaction 3. 
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Figure B.S11. 1H-13C HMBC NMR (THF-d8) Spectrum of Reaction 3. 
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Figure B.S12. 13C-DEPT (THF-d8, 101 MHz) Spectrum of Reaction 3. 
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Figure B.S13. 1H NMR (THF-d8, 400 MHz) Spectrum of Reaction 1. 
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Figure B.S14. 1H NMR (THF-d8, 400 MHz) Spectrum of Reaction 2. 
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Figure B.S15. 1H NMR (THF-d8, 400 MHz) Spectrum of Reaction 3 
(after 10 min). 
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Figure B.S16. 1H NMR (THF-d8, 400 MHz) Spectrum of Reaction 4. 
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Computational Details 
 Geometry optimizations on all intermediates and transition states were performed using the 
B3LYP4 method of density functional theory (DFT) in the gas phase with a mixed basis set using 
LANL2DZ for ruthenium and 6-31G(d) for all other atoms. Frequency calculations were 
performed on all optimizations to confirm the location of relative minima (zero negative 
frequencies) and transition states (one negative frequency). Thermal corrections were computed 
from frequency calculations at the standard state of 1 atm and 298 K. All frequencies below 100 
cm-1 were manually adjusted to 100 cm-1 to account for the breakdown of the harmonic oscillator 
approximation, as discussed by Truhlar and coworkers. 5  Intrinsic reaction coordinate (IRC) 
calculations were performed at the same level of theory on most transition states to confirm the 
connection of the transition states to the calculated intermediates. Single point energy calculations 
were performed on all optimized structures using the M066 functional and a mixed basis set using 
SDD for ruthenium and 6-311+G(d,p) for all other atoms. The SMD 7  solvation model for 
tetrahydrofuran as employed for all single point calculations. Electrostatic potential maps were 
generated from the respective optimizations of the 2 structures. All calculations were performed 
using the Gaussian 09 software.8 All 3D structures were rendered using CYLView.9  
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Figure B.S17. Decomposition pathway of 8 leading to hydride 10. 
 
Figure B.S18. Decomposition pathway of 11’ to hydride SI-10. 
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Figure B.S19. Electrostatic potential maps of 11 (top) and 11’ (bottom). 
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Supplemental Information for Chapter 2.2 
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(Experimental and spectral data provided by T. Patrick Montgomery) 
Ruthenium Catalyst 4 
 
Figure C.S1. Catalyst 4-up.  
1H NMR (400 MHz, CDCl3): δ 14.05 (s, 0.28H), 13.97 (s, 0.72H), 11.72 (d, J = 8.6 Hz, 0.75H), 
10.87 – 10.78 (m, 0.29H), 7.83 (dd, J = 7.8, 1.6 Hz, 0.83H), 7.71 (d, J = 8.2 Hz, 0.26H), 7.69 – 
7.66 (m, 0.27H), 7.62 (td, J = 6.5, 3.5 Hz, 1H), 7.59 (d, J = 6.0 Hz, 0.85H), 7.56 – 7.49 (m, 2H), 
7.38 (d, J = 8.6 Hz, 0.28H), 7.34 – 7.18 (m, 4H), 7.16 (d, J = 8.4 Hz, 0.83H), 6.98 (d, J = 31.5 Hz, 
2H), 6.82 – 6.71 (m, 1H), 6.59 (dd, J = 7.5, 1.7 Hz, 0.94H), 6.55 (dd, J = 7.5, 1.6 Hz, 0.42H), 6.25 
(s, 1H), 5.43 (hept, J = 6.6 Hz, 0.3H), 5.19 (hept, J = 6.5 Hz, 0.83H), 4.07-3.85 (m, 4H), 2.94 (s, 
2H), 2.73 – 2.34 (m, 4H), 2.14 (d, J = 57.4 Hz, 10H), 1.77 (d, J = 6.5 Hz, 1H), 1.61 (dd, J = 6.5, 
3.4 Hz, 4H), 1.47 (d, J = 6.4 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 248.94, 248.61, 220.27, 220.06, 157.07, 155.71, 155.52, 151.58, 
143.90, 143.01, 142.96, 139.15, 138.67, 137.85, 137.30, 136.99, 136.52, 134.51, 134.38, 133.40, 
132.58, 131.44, 131.20, 131.07, 130.63, 130.56, 130.27, 130.00, 129.56, 129.19, 128.98, 128.95, 
128.48, 128.29, 128.15, 128.11, 127.54, 127.46, 125.46, 125.37, 125.33, 125.14, 125.00, 124.32, 
124.18, 124.08, 123.48, 122.90, 122.81, 122.39, 116.31, 116.05, 81.67, 80.92, 52.29, 52.24, 24.35, 
24.09, 22.26, 22.17, 21.25, 21.20, 19.84, 18.04. 
 
HRMS (FAB+): [M]+ C45H46N2OS2Ru Calculated: 796.2096, Found: 796.2104. 
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Figure C.S2. Portion of 1H-NMR of 4. 
 
Figure C.S3. X-ray Crystal Structure of 4. 
Ruthenium Catalyst 5 
 
Figure C.S4. Catalyst 5-up. 
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1H NMR (400 MHz, THF-d8): δ 14.04 (s, 0.4H), 13.99 (s, 0.6H), 11.57 (s, 0.6H), 10.74 (s, 0.4H), 
7.73 (dd, J = 8.2, 1.6 Hz, 0.6H), 7.68 (dd, J = 8.2, 1.7 Hz, 0.4H), 7.57 (d, J = 8.0 Hz, 0.4H), 7.53 
(dd, J = 8.0, 1.3 Hz, 1H), 7.48 (d, J = 8.5 Hz, 0.6H), 7.35 (d, J = 16.0 Hz, 0.6H), 7.33 (d, J = 20.0 
Hz, 0.4H), 7.28 – 7.20 (m, 2H), 7.17 (dd, J = 8.2, 3.5 Hz, 2H), 7.04 – 6.84 (m, 2H), 6.75 (q, J = 
7.2 Hz, 1H), 6.54 (ddt, J = 17.8, 8.9, 2.8 Hz, 1H), 6.43 (s, 1.4H), 6.15 (s, 0.6H), 5.49 – 5.40 (m, 
0.4H), 5.40 – 5.29 (m, 0.6H), 4.05 (d, J = 9.4 Hz, 1.6H), 3.98 – 3.78 (m, 2.4H), 2.87 (s, 2H), 2.73 
(s, 2H), 2.66 – 2.39 (m, 5H), 2.29 – 2.04 (m, 8H), 1.84 – 1.46 (m, 11H). 
 
13C NMR (101 MHz, THF-d8): δ 248.22, 247.39, 220.38, 220.01, 156.65, 155.51, 155.47, 151.73, 
143.44, 143.02, 142.99, 139.11, 138.99, 138.57, 138.04, 137.70, 137.28, 136.92, 136.37, 136.04, 
133.55, 133.49, 133.26, 132.57, 132.47, 132.36, 131.33, 131.28, 130.82, 130.72, 130.55, 130.36, 
130.19, 130.04, 129.65, 129.15, 128.77, 128.23, 128.03, 127.99, 127.60, 127.40, 127.35, 127.05, 
126.94, 125.14, 125.04, 124.98, 124.04, 123.54, 122.82, 122.26, 116.35, 116.26, 81.67, 81.33, 
52.36, 52.23, 52.15, 24.28, 24.18, 22.89, 22.50, 22.18, 21.24, 21.18, 20.14, 19.80, 17.94. 
 
HRMS (FAB+): [M]+ C46H48N2OS2Ru Calculated: 810.2252, Found: 810.2240. 
 
NOE Spectrum of 4 
 
Figure C.S5. Proton at the 5-position of the phenanthrene dithiolate is at 11.72 ppm for the up 
isomer and 10.83 for the down isomer. 
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Figure C.S6. NOE Spectra of 4.  
 
161 
 
 
Figure C.S7. Portion of NOE Spectra of 4.  
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Figure C.S8. 3D side views of 6-down (left) and 6-up (right) with free energy difference shown 
with 2D images. Bottom left shows front view of 6-down with distances to isopropyl group 
indicated. Bottom right shows a side view of 6-mcb with distance of the tert-butyl to metallacycle 
β-substituent. 
To see if a substituent larger than methyl would change the preference for the two isomers and 
have a greater influence on the metallacycle, we computed the structure of catalyst 6. The up and 
down isomers are shown in Figure 2.2.5. The larger substituent was predicted to favor the up 
position by an even larger ratio (7:1) than previous catalysts. The tert-butyl group has a closer 
proximity to the isopropyl group of the Hoveyda chelate as shown in the front view. The 
metallacycle (6-mcb) also indicates that the tert-butyl group will still not likely significantly hinder 
Z-olefin metathesis. 
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QM calculations 
 All QM calculations were performed with Gaussian09.1 Conformational searches were performed 
using MMFF2 in Spartan.3 Geometry optimizations and frequencies calculations were performed 
at the B3LYP 4  level with LANL2DZ for iron and 6-31G(d) for all other atoms. Transition 
structures contained one negative frequency. Enthalpies and free energies were computed at 1atm 
and 298.15K. A correction to the entropy was applied in accordance with the work of Truhlar et 
al. 5  Single point energy computations were performed at the B3LYP-D3(BJ) 6  level with 
LANL2DZ for iron and 6-311+G(d,p) and CPCM7 for water.  
MD simulations 
 The heme iron(IV)-oxo complex involved in the cytochrome-catalyzed oxidative hydroxylation 
cycle (compound I) was used to model the active form of the cofactor. Simulations were performed 
using the GPU code (pmemd)8 of the Amber 12 package.9 The Amber-compatible parameters 
developed by Cheatham et al.10 were used for compound I and its axial Cys ligand. Parameters for 
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macrolactone substrates were generated within the antechamber module using the general AMBER 
force field (gaff),11 with partial charges set to fit the electrostatic potential generated at the HF/6-
31G(d) level by the RESP model.12 The charges were calculated according to the Merz-Singh-
Kollman scheme13 using Gaussian 09.1 Each protein was immersed in a pre-equilibrated truncated 
cuboid box with a 10 Å buffer of TIP3P14 water molecules using the tleap module, resulting in the 
addition of around 11370 solvent molecules. The systems were neutralized by addition of explicit 
counter ions (Na+ and Cl-). All subsequent calculations were done using the widely tested Sony 
Brook modification of the Amber 99 force field (ff99sb).15  The substrate and enzyme were 
optimized for total 1000000 steps, with 750000 steepest descent steps and 250000 conjugate 
gradient steps. The systems were gently heated using six 50 ps steps, incrementing the temperature 
by 50 K for each step (0-300 K) under constant-volume and periodic-boundary conditions. Water 
molecules were treated with the SHAKE algorithm such that the angle between hydrogen atoms 
were kept fixed. Long-range electrostatic effects were modelled using the particle-mesh-Ewald 
method.16 An 8 Å cutoff was applied to Lennard-Jones and electrostatic interactions. Harmonic 
restraints of 30 kcal/(mol Å2) were applied to the solute and the Andersen equilibration scheme 
was used to control and equalize the temperature. The time step was kept at 1 fs during the heating 
stages, allowing potential inhomogeneities to self-adjust. Each system was then equilibrated for 2 
ns with a 2 fs time step at a constant volume. Production trajectories were then run for an additional 
500 ns under the same simulation conditions.  
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Figure D.S1. The two low energy conformers and the barriers to C-H abstraction of the two 
possible β-hydrogens. The favored hydrogen for oxidation is circled in each conformer.  
 
 
Figure D.S2. 500 ns MD simulation for substrate 4d.  
Analysis of β-oxidation 
From the QM model computations, the two conformers of the model of 4 favor different 
hydrogens for abstraction, unlike the allylic and α-positions. Both hydrogens have low barriers to 
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abstraction when in one of the conformations. From the 500 ns MD simulation, the tether places 
Cα 3.9 Å and Cβ 4.0 Å away from the iron-oxo. Comparison of the equatorial (Hup) and axial 
(Hdown) hydrogens over the course of the 500ns simulation shows that Hup is the closest to the iron-
oxo for nearly 300 ns before moving far from the catalytic center. Hdown remains at a constant 
distance around 4Å, which is seemingly not close enough facilitate catalysis.  
 
Figure D.S3. Results of 500 ns MD simulation for substrate 14e. Average bond distances shown 
in snapshot on the left.  
 
 
 
 
Hup 
Hdown 
Hup 
Hdown 
Major 
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Materials and Methods 
Materials.  
Nicotinamide adenine dinucleotide phosphate (reduced) (NADPH) was purchased from Enzo 
BioSciences. Deuterated water (D2O) was purchased from Sigma-Aldrich. The GsfF & Aspergillus 
terreus cytochrome P450 reductase co-expression plasmid pESC-GsfF/AtCPR was used 
previously and constructed as described in Cacho et al.1 The Penicillium aethiopicum mutant 
strains ΔgsfF and ΔgsfD were obtained from previous study in Cacho et. al.1 All other chemicals 
and media components were purchased from Fisher Scientific. 
Experimental Procedures 
Purification and characterization of Griseophenone B and desmethyl-dehydrogriseofulvin. 
Griseophenone B and desmethyl-dehydrogriseofulvin were isolated and purified from ΔgsfF and 
ΔgsfD mutant strains of Penicillium aethiopicum as described in Cacho et al. 1 Briefly, a 3 L of 
mutant cultures of P. aethiopicum was extracted twice with ethyl acetate and evaporated to 
dryness. The dried extract was subjected to purification using Sephadex LH-20 and high 
performance liquid chromatography equipped with Phenomenex Luna 5μ 250 x 10mm C18 
reverse-phase column. NMR characterization (1D 1H and 13C, 2D HSQC and HMBC) of the 
purified compound was then performed on a Bruker AV500 NMR (500 MHz) equipped with 5mm 
dual cryoprobe at the UCLA Molecular Instrumentation Center. 
Isolation of yeast microsomes containing GsfF and A. terreus cytochrome P450 reductase. 
Yeast microsome extraction was adapted from the method described by Ralston et al and Barriuso 
et al and was done as described in Cacho et al.1-3 Overnight seed culture of Saccharomyces 
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cerevisiae strain BJ5464-NpgA4 harboring the expression plasmid pESC-gsfF/AtCPR was 
inoculated into 500 mL synthetic leucine dropout media with galactose (SGMM, -Leu) and grown 
at 28 °C with shaking speed at 250 rpm for 24 hours after induction and were pelleted by 
centrifugation at 4 °C. After washing and of the cell pellet in 100 mL TES buffer (50 mM Tris-
HCl pH 7.5, 1 mM EDTA and 0.6 mM sorbitol) with 10 mL 2-mercaptoethanol, the cells were 
pelleted again and resuspended in 5 mL extraction buffer ((TES buffer supplemented with 1% 
bovine serum albumin and 2 mM β-mercaptoethanol and 1mM phenylmethylsulfonyl fluoride 
(Sigma-Aldrich)). The resuspended yeast cells were lysed using Zirconia/silica beads. Cellular 
debris was removed from the lysate by centrifugation at 10,000g and 4°C for 10 min. The 
microsomal fraction was isolated from the clarified lysate by centrifugation at 100,000g and 4 °C 
for 70 min. The microsomal pellets were weighed prior to resuspension in 1.5 mL of TEG-M buffer 
(50 mM Tris–HCl, pH 7.5, 1 mM EDTA, 20% glycerol, and 1.5 mM 2-mercaptoethanol) and 
stored frozen at -80 °C. Final concentration of protein in microsome as measured by Bradford 
assay was 180 µg per mL. 
Assay of GsfF using griseophenone B as substrate: The GsfF in vitro assay was performed in a 
100 µL reaction volume and 30 °C by addition of a final concentration of microsomal protein of 
0.18 µg/µL to 100 mM Tris-HCl pH 7.5, 0.1 µg/µL bovine serum albumin, 20 -100 µM 
griseophenone B and 2 mM NADPH. Initial reaction velocities were obtained for all the substrate 
concentration using the given condition. Ten microliter aliquots of the reaction were taken at five 
minute intervals and quenched via addition of acetonitrile to a final volume of 80%. 
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The timepoint samples were subjected to LCMS analysis with a Shimadzu 2020 Liquid 
Chromatograpy Mass Spectrometer; with the mass spectrometer in a selective-ion-monitoring 
mode and set to specifically detect the substrate and product from the reaction. Samples were 
separated on a Phenomenex Kinetex (1.7 μ pore size, 100 Å particle size, 100 x 2 mm) C18 reverse-
phase column using a flow rate of 0.3 mL/min on a linear gradient of 5-95% solvent B in 10 min 
followed by isocratic 95% solvent B for another 2.5 min (solvent A: water with 0.1% (v/v) formic 
acid, solvent B: acetonitrile with 0.1% (v/v) formic acid). The total yield of 14 was measured by 
comparing the area under the chromatogram peak of 14 against a standard curve of known amount 
of 14 injected and analyzed by LCMS. 
The GsfF in vitro assay in D2O was performed and analyzed as the same manner as above except 
the reaction was performed such that the final concentration of deuterium is ~96%. 
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Figure E.S1. (Top) Conversion of 1 to 2 showing the expected mass-to-charge ratio (m/z) of the 
species in the reaction. (Bottom) Extracted ion chromatogram of 1 (m/z = 339, in black) and 2 
(m/z = 337, in red) from the LCMS analysis of the GsfF reaction performed in water (trace i) and 
D2O (trace ii) showing conversion of 1 to 2. The LCMS trace for product 2 was also obtained as 
comparison (trace iii). 
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Figure E.S2. Reaction rates of GsfF in 20 µM, 50 µM and 100 µM 1 in water (black) and 
deuterated water (red). Taking the ratio of the rates in water and D2O gives an average deuterium 
kinetic isotope effect of 1.90±0.29.  
 
Figure E.S3. Standard curve used to quantify the amount of 14 in the injected samples from the 
quenched reaction.  
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Table E.S1. NBO Charges of 1  
Atom No Charge 
C 1 0.37089 
C 2 -0.17044 
C 3 0.37009 
C 4 -0.3008 
C 5 0.42256 
C 6 -0.37147 
H 7 0.23085 
C 8 0.52987 
C 9 -0.14937 
C 10 0.00264 
C 11 0.33847 
C 12 -0.31237 
C 13 -0.34459 
C 14 0.35947 
H 15 0.20597 
H 16 0.23229 
C 17 -0.59986 
H 18 0.23666 
H 19 0.21823 
H 20 0.20706 
O 21 -0.65528 
H 22 0.49531 
O 23 -0.53348 
O 24 -0.66499 
H 25 0.47362 
O 26 -0.51327 
O 27 -0.66798 
H 28 0.50076 
Cl 29 0.03474 
O 30 -0.62381 
C 31 -0.21133 
H 32 0.17648 
H 33 0.19689 
H 34 0.17667 
C 35 -0.20927 
H 36 0.19836 
H 37 0.17451 
H 38 0.17776 
 
 
 
 
 
176 
 
Table E.S2. NBO Charges of 6-TS-
doublet 
Atom No Charge 
Fe 1 0.34958 
O 2 -0.42574 
C 3 -0.18046 
N 4 -0.44402 
C 5 0.16449 
C 6 0.15585 
C 7 -0.21541 
H 8 0.21471 
C 9 -0.22745 
H 10 0.21291 
N 11 -0.43675 
C 12 0.16216 
C 13 0.16816 
C 14 -0.20982 
H 15 0.21579 
C 16 -0.21633 
H 17 0.21515 
N 18 -0.42678 
C 19 0.1629 
C 20 0.14317 
C 21 -0.24489 
H 22 0.21521 
C 23 -0.13683 
H 24 0.20643 
N 25 -0.43997 
C 26 0.15929 
C 27 0.16331 
C 28 -0.22472 
H 29 0.21515 
C 30 -0.21746 
H 31 0.21576 
C 32 -0.19144 
C 33 -0.18765 
C 34 -0.18928 
H 35 0.21397 
H 36 0.21579 
H 37 0.21217 
H 38 0.21488 
S 39 0.0576 
C 40 -0.71547 
H 41 0.20287 
H 42 0.20274 
H 43 0.2134 
C 44 0.35391 
177 
 
C 45 -0.17045 
C 46 0.32408 
C 47 -0.15776 
C 48 0.38634 
C 49 -0.36609 
H 50 0.23559 
C 51 0.54493 
C 52 -0.02164 
C 53 0.07211 
C 54 0.44658 
C 55 -0.29733 
C 56 -0.36048 
C 57 0.39843 
H 58 0.20804 
H 59 0.23276 
C 60 -0.59715 
H 61 0.24903 
H 62 0.21965 
H 63 0.20351 
O 64 -0.66915 
H 65 0.48833 
O 66 -0.51227 
O 67 -0.6497 
H 68 0.47722 
O 69 -0.51952 
O 70 -0.66622 
H 71 0.50421 
Cl 72 0.00518 
O 73 -0.59009 
C 74 -0.2115 
H 75 0.17716 
H 76 0.1966 
H 77 0.1774 
C 78 -0.21134 
H 79 0.1964 
H 80 0.19205 
H 81 0.17271 
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Figure E.S4. Energy Diagram for Initial Abstraction from Ring A 
  
Figure E.S5. Scan of Second H-Abstraction from Intermediate 8b 
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Table E.S3. Bond distances and energies of scan in Figure E.S5 
Ha-OFe Distance 
(Å) 
Energy 
(Hartree) 
Relative Energy 
(kcal/mol) 
3.995985813 -3155.340032 0 
3.795985813 -3155.339859 0.108584244 
3.595985813 -3155.341336 -0.818623794 
3.395985813 -3155.341036 -0.63017014 
3.195985813 -3155.340629 -0.375018503 
2.995985813 -3155.341476 -0.906562975 
2.795985813 -3155.342887 -1.79200398 
2.595985813 -3155.345042 -3.143879071 
2.395985813 -3155.348113 -5.07126195 
2.195985813 -3155.35237 -7.742607542 
1.995985813 -3155.35817 -11.38214382 
1.795985813 -3155.365253 -15.82676223 
1.595985813 -3155.37309 -20.74472361 
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Figure F.S1. Ortiz de Montellano proposed alternate mode for formation of 8. 
Ortiz de Montellano1 proposes that 7-OH could be converted to 8 as shown but Tang and 
coworkers have shown that 7-OH is not converted to 4.2 
 
Figure F.S2. CYLview images of 16x (left) and 17x (right). Both structures were formed 
spontaneously upon optimization of various conformers of 7x.  XYZ coordinates are made 
available below.    
16x 17x 
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